Abstract

The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP 2 receptor.

Claims

1 . A method of using a compound of the formula I in which A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 3 and/or R 4 , R 1 is a hydrogen, a C 1 -C 6 -alkyl radical which may optionally be substituted, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl, where this radical can be substituted in any way, R 3 is a hydrogen, halogen, amino, an —S(O) p —C 1 -C 6 -alkyl group, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 or NH—CO—C 1 -C 6 -alkyl radical, a C 1 -C 6 -alkyl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 6 -acyl-, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates, where the following compounds are excluded: N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 4-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide. 2 . The compound as claimed in claim 1 , where A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 4 and/or R 3 , is a hydrogen or C 1 -C 6 -alkyl radical which may be substituted one or more times by halogen, is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl radical which may be substituted one or more times by halogen, R 2 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 6 -acyl-, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1-7 C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. 3 . The compound as claimed in claim 1 , where A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 4 and/or R 3 , is a hydrogen or a C 1 -C 6 -alkyl group which is substituted one or more times by halogen, is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or a C 1 -C 6 -alkyl group which is substituted one or more times by halogen, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , SO 2 NH 2 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 6 -acyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl, which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. 4 . The compound as claimed in claim 1 , where A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 4 and/or R 3 , R 1 is a hydrogen or a C 1 -C 6 -alkyl group which is substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl group which is substituted one or more times by halogen, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 6 -acyl-, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), N—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 12 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. 5 . The compound as claimed in claim 1 , where A is a phenyl, naphthyl or heteroaryl radical which may optionally be substituted once or twice by R 3 and/or R 4 , R 1 is a hydrogen or a C 1 -C 6 -alkyl group which may be substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl group, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 4 -alkyl, where p is 0-2, C 1 -C 4 -acyl-, —O—CO—NH(C 1 -C 4 -alkyl), —O—CO—N(C 1 -C 4 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 4 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 or a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. 6 . The compound as claimed in claim 1 , where A is a phenyl, naphthyl or heteroaryl radical which may optionally be substituted once or twice by R 3 and/or R 4 , R 1 is a hydrogen or a C 1 -C 6 -alkyl radical which is substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl radical which is substituted one or more times by halogen, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 4 -alkyl, where p is 0-2, C 1 -C 4 -acyl-, —O—CO—NH(C 1 -C 4 -alkyl), —O—CO—N(C 1 -C 4 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 4 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 or a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. 7 . The compound as claimed in claim 1 , where A is a phenyl, naphthyl or heteroaryl radical which may optionally be substituted once or twice by R 3 and/or R 4 , R 1 is a hydrogen or a C 1 -C 4 -alkyl radical which is substituted once, twice or three times by chlorine, fluorine, or bromine, R 2 is a hydrogen, chlorine, fluorine, bromine, cyano, an OCH 3 group or a C 1 -C 4 -alkyl radical which is substituted once, twice or three times by chlorine, fluorine or bromine, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once or twice, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is a CF 3 radical, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 4 -acyl-, —O—CO—NH(C 1 -C 4 -alkyl), —O—CO—N(C 1 -C 4 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 4 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or twice, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -alkyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once or twice, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is a CF 3 radical, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or twice, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. 8 . The compound as claimed in claim 1 selected from a group which comprises the following compounds: 1. biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 2. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4,5-trimethoxybenzamide 3. 4-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 4. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methylbenzamide 5. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 6. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-trifluoromethylbenzamide 7. 3-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 8. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methoxybenzamide 9. 4-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 10. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methylbenzamide 11. 4-tert-butyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 12. benzo[1,3]dioxole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 13. thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 14. quinoxaline-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 15. 5-phenylpyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 16. 5-phenyl-1H-pyrrole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 17. N-[2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 18. -N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methanesulfinylbenzamide 19. N-[2-(7-fluoro-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 20. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-[1,2,4]triazol-1-ylmethylbenzamide 21. thieno[2,3-b]pyrazine-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 22. N-[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 23. N-[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 24. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methanesulfonylbenzamide 25. N-[2-(4-bromo-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 26. 1H-benzotriazole-5-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 27. 1H-indole-2-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 28. 4′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 29. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-N′-pyridin-3-yl-terephthalamide 30. 4-amino-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 31. 5-bromofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 32. N-[2-(7-fluoro-2,4 dimethyl-1H-indol-3-yl)ethyl]-isonicotinamide 33. N-[2-(7-fluoro-2,4 dimethyl-1H-indol-3-yl)ethyl]benzamide 34. 2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 35. 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 36. 1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 37. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-methylnicotinamide 38. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methoxybenzamide 39. 4-ethoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 40. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxy-3,5-dimethoxybenzamide 41. 1H-benzotriazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 42. 5-methylthiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 43. 1H-pyrrole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 44. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylaminobenzamide 45. thiophene-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 46. 6-cyano-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 47. 1H-benzoimidazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 48. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-trifluoromethylbenzamide 49. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxy-3-methoxybenzamide 50. 4-dimethylamino-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 51. 4-cyano-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 52. isoxazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 53. 4-acetyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 54. 4-chloro-3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 55. 4-chloromethyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 56. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,5-dimethylbenzamide 57. 3,4-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 58. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-propylbenzamide 59. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-hydroxy-4-methylbenzamide 60. 2,3-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 61. 3,5-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 62. naphthalene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 63. 5-chlorothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 64. 6-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 65. 3-chloromethyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 66. 4-butoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 67. 4-acetoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 68. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methylsulfanylbenzamide 69. 4-cyano-2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 70. isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 71. isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 72. isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 73. 3,5-dichloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 74. quinoline-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 75. quinoline-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 76. 4-hydroxy-2-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 77. benzo[b]thiophene-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 78. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-hydroxybenzamide 79. pyrazine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 80. furan-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 81. quinoline-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 82. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 83. 4-benzyloxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 84. 5-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 85. 1H-indole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 86. 3-bromothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 87. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 88. 2-methylfuran-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 89. 1H-imidazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 90. 4-oxo-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 91. 4′-bromobiphenyl-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 92. 2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-iodobenzamide 93. 2,3-dihydrobenzofuran-7-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 94. 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 95. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2,5-dimethylbenzamide 96. 5-acetylthiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 97. quinoline-8-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 98. 2-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 99. 6-phenylpyrimidine-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 100. 1-methyl-1H-indole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 101. 2-pyridin-3-ylthiazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 102. 2,5-dimethyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 103. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-phenoxymethylbenzamide 104. 2,3-dihydrobenzofuran-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 105. 1H-indole-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 106. 2-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4,5-dimethoxybenzamide 107. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-pyrrolidin-1-ylbenzamide 108. quinoline-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 109. 5-phenyl-1H-pyrazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 110. pyridazine-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 111. 5-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 112. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-pyrrol-1-ylnicotinamide 113. pyrimidine-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 114. benzo[b]thiophene-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 115. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-piperidin-1-ylbenzamide 116. pyrazolo[1,5-a]pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 117. quinoxaline-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 118. 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methoxybenzamide 119. 3-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 120. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-phenoxbenzamide 121. thiazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 122. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methylbenzamide 123. 3-chloro-2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 124. 5-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 125. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 126. 5-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 127. 4-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 128. 6-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 129. 4-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 130. 4-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 131. 7-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 132. 6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 133. 6-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 134. 5-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 135. 1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 136. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 137. 5-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 138. 6-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 139. 4-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 140. 4-dimethylamino-N-[2-(7-fluoro-1H-indol-3-yl)ethyl]benzamide 141. N-[2-(7-fluoro-1H-indol-3-yl)ethyl]-4-pyrrolidin-1-ylbenzamide 142. 1H-indole-6-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 143. 4-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 144. 4-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 145. 6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 146. 6-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 147. 7-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 148. 5-bromo-2,3-dihydrobenzofuran-7-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 149. 4-(1H-benzoimidazol-2-yl)-N-[2-(7-fluoro-1H-indol-3-yl)ethyl]benzamide 150. 4-(1H-benzoimidazol-2-yl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 151. N-[2-(4-cyano-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 152. [1,1′; 4′,1″]terphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 153. 3′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 154. 3′-fluoro-4′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 155. 2′-fluoro-4′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 156. 4′-hydroxymethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 157. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-4-carboxylic acid 158. 4′-tert-butylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 159. 4′-chlorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 160. 3′,4′,5′-trimethoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 161. 3′-trifluoromethoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 162. 4′-trifluoromethoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 163. 3′-hydroxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 164. 4′-methanesulfinylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 165. 3′-cyanomethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 166. 2′-acetylaminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 167. 3′-fluoro-4′-methoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 168. 3′-chloro-4′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 169. 3′,4′-difluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 170. 3′,5′-difluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 171. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(5-hydroxymethyl-thiophen-2-yl)-benzamide 172. 3′-methanesulfonylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 173. 4-fluoro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-3-carboxylic acid 174. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-methoxy-biphenyl-4-carboxylic acid methyl ester 175. 5-fluoro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]biphenyl-3-carboxylic acid 176. 3-chlorobiphenyl-4,4′-dicarboxylic acid 4-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 177. 3-chlorobiphenyl-4,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}4-methylamide 178. 3′-dimethylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 179. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-thiazol-2-ylamide 180. 4′-methylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 181. 4′-dimethylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 182. biphenyl-3,4′-dicarboxylic acid 3-diethylamide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 183. biphenyl-4,4′-dicarboxylic acid 4-diethylamide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 184. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]biphenyl-3-carboxylic acid 185. biphenyl-4,4′-dicarboxylic acid 4-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 186. 3′-methylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 187. 3′-trifluoromethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 188. 4′-methylsulfanylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 189. 4′-acetylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 190. 3′-aminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 191. 3′-acetylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 192. 3′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 193. [1,1′; 3′,1″]terphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 194. 3′-hydroxymethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 195. 4-benzo[b]thiophen-3-yl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 196. 4′-trifluoromethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 197. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-((E)-styryl)benzamide 198. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-quinolin-6-ylbenzamide 199. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(6-methoxypyridin-3-yl)-benzamide 200. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-methylamide 201. biphenyl-4,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}4-methylamide 202. 2′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 203. 2′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 204. 3′-acetylaminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 205. 4-benzo[1,3]dioxol-5-yl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 206. 3′-cyanobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 207. 4′-cyanomethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 208. biphenyl-3,4′-dicarboxylic acid 3-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 209. 3′,5′-dimethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 210. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-quinolin-3-ylbenzamide 211. 4′-acetylaminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 212. 3′-fluoro-5′-methoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 213. 5-fluorobiphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-methylamide 214. 3′-(acetylaminomethyl)biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 215. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(1-methyl-1H-indol-5-yl)benzamide 216. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(1-methyl-1H-indol-2-yl)benzamide 217. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-pyrrol-1-ylnicotinamide 218. N-[2-(4-cyano-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 219. 5-benzyloxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 220. 5-hydroxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 221. 5-methoxybenzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 222. 6-hydroxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 223. N-[2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 224. 3H-benzotriazole-5-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 225. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 226. quinoxaline-6-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 227. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}acetic acid methyl ester 228. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}butanoic acid ethyl ester 229. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}pentanoic acid ethyl ester 230. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}hexanoic acid ethyl ester 231. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}acetic acid methyl ester 232. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}butanoic acid ethyl ester 233. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}pentanoic acid ethyl ester 234. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}hexanoic acid ethyl ester 235. 6-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 236. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 237. 4-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 238. 6-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 239. {3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}acetic acid methyl ester 240. 4-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}butanoic acid ethyl ester 241. 5-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}pentanoic acid ethyl ester 242. 2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}acetic acid 243. 4-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}butanoic acid 244. 5-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}pentanoic acid 245. 6-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}hexanoic acid ethyl ester 246. 5-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}pentanoic acid 247. 6-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}hexanoic acid 248. 4-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}butanoic acid 249. 6-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}hexanoic acid 250. 4-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}butanoic acid 251. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}acetic acid 252. 4-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}butanoic acid ethyl ester 253. 5-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}pentanoic acid ethyl ester 254. 6-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}hexanoic acid ethyl ester 255. 6-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}hexanoic acid 256. 4-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}butanoic acid 257. 5-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}pentanoic acid 258. 6-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}hexanoic acid 259. 5-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}pentanoic acid 260. 2-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]isonicotinamide 261. {4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}acetic acid 262. 5-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 263. 6-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 264. 5-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 265. 6-(3-carbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 266. 6-(3-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 267. 6-(3-hydroxyphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 268. 4-(3-carbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 269. 4-(3-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 270. 4-(3-hydroxyphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 271. 4-(4-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 272. 5-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 273. benzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 274. 5-chloro-benzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 275. 4-bromo-3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 276. 4-chloro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]biphenyl-3-carboxylic acid 277. {3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}acetic acid 278. 5-(3-carbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 279. 5-(3-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 280. 5-(3-hydroxyphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 281. 6-(3-carbamoylphenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 282. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(3-methylcarbamoyl-phenyl)nicotinamide 283. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(3-hydroxyphenyl)nicotinamide 284. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(4-methylcarbamoyl-phenyl)nicotinamide 285. 5-(3-carbamoylphenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 286. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(3-methylcarbamoyl-phenyl)nicotinamide 287. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(3-hydroxyphenyl)nicotinamide 288. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(4-methylcarbamoyl-phenyl)nicotinamide 289. 2-(3-carbamoylphenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]isonicotinamide 290. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-(3-methylcarbamoyl-phenyl)isonicotinamide 291. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-(3-hydroxyphenyl)isonicotinamide 292. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-(4-methylcarbamoyl-phenyl)isonicotinamide 293. benzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 294. quinoline-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 295. [1,8]naphthyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 296. isoquinoline-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 297. 5-pyridin-2-yl-thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 298. 5-trifluoromethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 299. 5-fluoro-1H-indole-2-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 300. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 301. 6-(3-trifluoromethoxyphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 302. 5-(4-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 303. 4′-methoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 304. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-methoxybiphenyl-4-carboxylic acid 305. 4′-methoxybiphenyl-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 306. 4-(4-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 307. 4-(3-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 308. 4-(3-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 309. 4-(3-hydroxyphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 310. 4-(3-carbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 311. 4-bromothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 312. 2-fluorobiphenyl-4,4′-dicarboxylic acid 4-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}4′-methylamide 313. 2′-fluorobiphenyl-3,4′-dicarboxylic acid 3-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 314. 2-fluoro-3′-hydroxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 315. 2′-fluorobiphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-methylamide 316. 5-(3-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 317. 5-bromothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 318. 3′-hydroxybiphenyl-4-carboxylic acid [2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 319. biphenyl-4,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}4-methylamide 320. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-hydroxybiphenyl-4-carboxylic acid methyl ester 321. N-[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-6-(3-methylcarbamoylphenyl)nicotinamide 322. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 323. 5-(3-carbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 324. 5-(3-hydroxyphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 325. 5-(4-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 326. 5-(3-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 327. 5-(3-carbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 328. 5-(3-hydroxyphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 329. 5-(4-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 330. 6-(3-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 331. 6-(3-carbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 332. 6-(3-hydroxyphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 333. 6-(4-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 334. 3′-cyano-2′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 335. 5-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 336. 5-chloro-1H-indole-2-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 337. 5-chloro-1H-indole-2-carboxylic acid [2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 338. 5-trifluoromethyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 339. 6-methanesulfonyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 340. 7-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 341. 4-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 342. 6-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 343. 7-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 344. 5-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 345. 5-trifluoromethyl-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 346. 5-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 347. 5-trifluoromethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 348. N-[2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 349. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 350. 5-fluoro-1H-indole-2-carboxylic acid [2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 351. 5-trifluoromethoxy-1H-indole-2-carboxylic acid [2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 352. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-hydroxybiphenyl-4-carboxylic acid 353. 4-bromo-N-[2-(4-fluoro-2,7-dimethyl-1H-indol-3-yl)ethyl]benzamide 354. 4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 355. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxybenzamide 356. 3′-(2,5-dioxoimidazolidin-4-yl)biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 357. 3-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 358. 5-bromobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 359. 6-bromobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 360. 6-trifluoromethylbenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361. 6-trifluoromethoxybenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 362. 5-trifluoromethoxybenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 363. benzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 364. 5-chlorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 365. 6-chlorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 366. 5-fluorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 367. 6-fluorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 368. 5-trifluoromethylbenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 369. 6-trifluoromethylbenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 370. 5-trifluoromethoxybenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 371. 6-trifluoromethoxybenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 372. 5-bromobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 373. 6-bromobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 374. benzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 375. 5-chlorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 376. 6-chlorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 377. 5-fluorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 378. 6-fluorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 379. 5-trifluoromethylbenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 380. 6-trifluoromethylbenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 381. 5-trifluoromethoxybenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 382. 6-trifluoromethoxybenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 383. 5-bromobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 384. 6-bromobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 385. 1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 386. 5-chloro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 387. 6-chloro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 388. 5-fluoro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 389. 6-fluoro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 390. 5-trifluoromethyl-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 391. 6-trifluoromethyl-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 392. 5-trifluoromethoxy-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 393. 6-trifluoromethoxy-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 394. 5-bromo-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 395. 6-bromo-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 396. 5-trifluoromethylsulfanyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 397. 5,6-dichloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 398. 5-chloro-6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 399. 5-fluoro-6-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 400. 5,6-difluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 401. 4,6-dichloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 402. 4,6-difluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 403. 5-acetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 404. 6-acetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 405. 5-(2,2-dimethylpropionylamino)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 406. 6-(2,2-dimethylpropionylamino)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 407. 5-trifluoroacetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 408. 6-trifluoroacetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 409. 5-isopropyloxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 410. 6-isopropyloxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 411. 5-isopropyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 412. 6-trifluoromethyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 413. 4,5,6,7-tetrahydro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 414. 3-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 415. 5-trifluoromethylbenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 416. 5-fluorobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 417. 5-amino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 418. 6-amino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 419. 6-dimethylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 420. 5-dimethylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 421. 6-methylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 422. 5-methylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 423. 6-carbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 424. 5-carbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 425. 6-tert-butyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 426. 5-tert-butyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 9 . The use of the compounds as claimed in claim 1 for the manufacture of medicaments which comprise at least one of the compounds of the formula I. 10 . A medicament as set forth in claim 9 with suitable formulating substances and carriers. 11 . A method of using the medicaments as set forth in claim 10 , for the treatment and prophylaxis of disorders. 12 . A method as in claim 11 for the treatment and prophylaxis of disorders connected with the EP 2 receptor. 13 . A method as in claim 11 for the treatment and prophylaxis of fertility impairments. 14 . A method as in claim 11 for the treatment and prophylaxis of painful menstruation. 15 . A method as in claim 11 for the treatment and prophylaxis of endometriosis. 16 . A method of using the compounds as claimed in claim 1 for modulating the EP 2 receptor. 17 . A method as in claim 11 for the treatment and prophylaxis of pain. 18 . A method of using the compounds and of the medicaments as set forth in claim 10 for controlling fertility/contraception. 19 . A method as in claim 11 for the treatment and prophylaxis of osteoporosis. 20 . A method as in claim 11 for the treatment and prophylaxis of cancer. 21 . A method of using the compounds of the general formula I as claimed in claim 1 in the form of a pharmaceutical product for enteral, parenteral, vaginal and oral administration.
[0001] This application claims the benefit of the filing date of U.S. Provisional Application Ser. No. 60/943,656 filed Jun. 13, 2007. [0002] The present invention relates to aryl/hetarylamide derivatives as EP 2 receptor modulators, process for their preparation, and their use as medicaments. [0003] It has long been known that prostaglandins are key molecules in the processes of female reproductive biology such as, for example, control of ovulation, of fertilization, of nidation, of decidualization (e.g. placenta formation) and of menstruation. Prostaglandins likewise play an important part in the pathological changes in the reproductive tract, including menorrhagia, dysmenorrhea, endometriosis and cancer. The mechanism by which prostaglandins bring about these changes has not yet been completely elucidated. Recent results indicate that prostaglandins, their receptors and signal transduction pathways thereof are involved in processes such as angiogenesis, apoptosis, proliferation, and in inflammatory/antiinflammatory and immunological processes. [0004] The effects of prostaglandins are mediated by their G protein-coupled receptors which are located on the cell surface. Prostaglandin E 2 (PGE 2 ) is of particular interest, having a wide variety of cellular effects through binding to functionally different receptor subtypes, namely the EP 1 , EP 2 , EP 3 and EP 4 receptors. The receptor subtypes to which prostaglandin E 2 binds appear to be of particular interest for the receptor-mediated effects which are involved in the control of fertility. It has thus been possible to show that the reproductive functions in EP 2 knockout mice (EP 2 −/− ), i.e. in mice no longer having a functional PGE 2 receptor of the EP 2 subtype, are impaired, and that these animals have a smaller “litter size” (Matsumoto et al., 2001, Biology of Reproduction 64, 1557-1565). It was likewise possible to show that these EP 2 knockout mice (Hizaki et al. Proc Natl Acad Sci U.S.A. 1999 Aug. 31; 96(18):10501-10506) show distinctly reduced cumulus expansion and severe subfertility, which is to be regarded as causally connected with diminished reproductive processes such as ovulation and fertilization. [0005] The EP 2 receptor accordingly represents an important target for developing medicaments for controlling female fertility. The existence of the 4 subclasses of the PGE 2 receptor opens up the possibility of targeted development of selectively active compounds. However, to date, scarcely any selective EP 2 receptor ligands which bind to the EP 2 subtypes of the PGE 2 receptor are known, since most known compounds also bind to the other PGE 2 receptor subtypes such as, for example, to the EP 4 receptor. [0006] EP 2 receptor antagonists are described, for example in the application US2005059742 (Jabbour, Medical Research Concil). A method in which an EP 2 and/or an EP 4 antagonist can be employed for the treatment of menorrhagia and dysmenorrhea is claimed. AH6809 is disclosed as antagonist of the EP 2 or EP 4 receptor, but no other specific antagonists and no new compounds are disclosed. [0007] In an earlier application of the same group (EP1467738), EP 2 or EP 4 antagonists are claimed for the treatment of pathological conditions such as, for example, allergic disorders, Alzheimer's disease, pain, abortion, painful menstruation, menorrhagia and dysmenorrhea, endometriosis, bone disorders, ischemia etc. The described compounds are, however, distinguished by a particularly high affinity for the EP 3 receptor. A further application (WO04/032964) describes novel compounds which are likewise distinguished by a particularly high affinity for the EP 3 receptor, but also have EP 2 -antagonistic effects and which are used for the treatment and prophylaxis of allergic disorders. [0008] Ono Pharmaceutical claims in the application WO03/016254 the preparation of benzene acid or saturated carboxylic acid derivatives which are substituted by aryl or heterocycles, inter alia as PGE 2 receptor antagonists. The disclosed compounds are claimed for the treatment of a large number of disorders, including allergic disorders, Alzheimer's disease, pain, abortion, painful menstruation, menorrhagia and dysmenorrhea, endometriosis, bone disorders, ischemia etc. The described compounds are, however, distinguished by a particularly high affinity for the EP 3 receptor. A further application (WO04/032964) describes novel compounds which are likewise distinguished by a particularly high affinity for the EP 3 receptor, but also have EP 2 -antagonistic effects and which are used for the treatment and prophylaxis of allergic disorders. [0009] The application WO04/39807 of Merck Frosst, Canada, discloses the preparation of pyridopyrrolizines and pyridoindolizines. However, these compounds are distinguished by good binding to the PGD 2 receptor, and this receptor represents a different subtype of the prostaglandin receptor. [0010] Naphthalene derivatives as EP 4 receptor ligands are disclosed in application US2004102508 of SmithKline Beecham Corporation. The claimed compounds are used for the treatment or prophylaxis of pain, allergic reactions and neurodegenerative disorders. [0011] EP 4 antagonists (γ-lactams) are claimed in the application WO03/103604 (Applied Research Systems). The compounds bind approximately 60-fold better to the EP 4 than to the EP 2 receptor and are claimed inter alia for the treatment of premature labor, dysmenorrhea, asthma, infertility or fertility impairments. The same company claims in the applications WO03/053923 (substituted pyrrolidines) or WO03/035064 (substituted pyrazolidinones) compounds for the treatment of disorders associated with prostaglandins, such as, for example, infertility, hypertension and osteoporosis. The compounds bind to the EP 4 - and to the EP 2 receptor subtypes. The application WO03/037433 claims ω-cycloalkyl, 17 heteroaryl prostaglandin derivatives as EP 2 receptor antagonists, in particular for the treatment of elevated intraocular pressure. [0012] The application WO03/064391 (Pfizer Products) describes metabolites of [3-[[N-(4-tert-butylbenzyl)(pyridin-3-ylsulfonyl)amino]methyl]acetic acid which inhibit the binding of [ 3 H] prostaglandin E 2 to the EP 2 receptor. The use of these metabolites for the treatment of osteoporosis is disclosed. [0013] Tani et al. claim in the application US2005124577 8-azaprostaglandin derivatives for the treatment of immunological disorders, allergic disorders, premature labor, abortion, etc. The compounds bind to the EP 2 and to the EP 4 receptor. [0014] European patent application EP 1306087 describes EP 2 receptor agonists which are used for the treatment of erectile dysfunction (Ono Pharmaceuticals). The same class of structures is described in European patent EP 860430 (Ono Pharmaceuticals), and their use for the manufacture of a medicament for the treatment of immunological disorders, asthma and abortion is claimed. WO04/009117 describes EP 2 and EP 4 receptor agonists for the treatment of disorders caused by uterine contraction, for example painful menstruation (Ono Pharmaceuticals). [0015] The applications WO03/74483 and WO03/09872 describe agonists which bind equally to the EP 2 and to the EP 4 receptor (Ono Pharmaceuticals). [0016] Agonists of the EP 2 and of the EP 4 receptors are frequently described in connection with the treatment of osteoporosis (WO99/19300 (Pfizer), US2003/0166631 (Dumont Francis), WO03/77910 (Pfizer), WO03/45371 (Pfizer), WO03/74483 and WO03/09872 (Ono Pharmaceuticals)) and for glaucoma treatment (WO04/37813, WO04/37786, WO04/19938, WO03/103772, WO03/103664, WO03/40123, WO03/47513, WO03/47417 (Merck Frosst Canada)) and U.S. Pat. No. 6,410,591 and U.S. Pat. No. 6,747,037 (Allergan). [0017] The patent application WO04/12656 (Applied Research Systems) claims EP 2 receptor agonists in connection with inflammation. [0018] The patent application WO03/77919 (Merck & Co. Inc.) claims EP 4 receptor agonists for the treatment of fertility. [0019] However, to date, no selective EP 2 receptor agonists and antagonists which control the processes which are ultimately responsible for ovulation, fertilization, nidation and decidualization and thus contribute to promoting or inhibiting fertility are known. [0020] It is therefore an object of the present invention to provide stable EP 2 receptor antagonists. [0021] This object is achieved by providing the compounds of the general formula I [0000] [0000] in which A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 3 and/or R 4 , R 1 is a hydrogen, a C 1 -C 6 -alkyl radical which may optionally be substituted, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl, where this radical can be substituted in any way, R 3 is a hydrogen, halogen, amino, an —S(O) p —C 1 -C 6 -alkyl group, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 or NH—CO—C 1 -C 6 -alkyl radical, a C 1 -C 6 -alkyl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl-, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates, which overcome the known disadvantages and have improved properties, i.e. good activity, good solubility and stability, where the following compounds are excluded: N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 4-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide. [0056] The compounds of the invention have an antagonistic effect on the EP 2 receptor and thus serve to control female fertility. [0057] C 1 -C 4 -Alkyl or C 1 -C 6 -alkyl means in each case a straight-chain or branched alkyl radical such as, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl and hexyl. [0058] The alkyl radicals may optionally be substituted one or more times, identically or differently, by halogen. [0059] C 1 -C 4 -Alkoxy or C 1 -C 6 -alkoxy means in each case a straight-chain or branched alkoxy radical such as, for example, methoxy-, ethoxy-, n-propoxy-, isopropoxy-, n-butoxy-, sec-butoxy-, isobutoxy-, tert-butyloxy-, pentoxy-, isopentoxy- and hexoxy-. [0060] The alkoxy radicals may optionally be substituted one or more times, identically or differently, by halogen. [0061] C 1 -C 4 -Acyl or C 1 -C 6 -acyl means in each case a straight-chain or branched radical such as, for example, formyl, acetyl, propionyl, butyryl, isobutyryl, valeryl and benzoyl. [0062] The acyl radicals may optionally be substituted one or more times, identically or differently, by halogen. [0063] C 3 -C 6 -Cycloalkyl means monocyclic alkyl rings such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. [0064] The cycloalkyl radicals may, instead of the carbon atoms, comprise one or more heteroatoms such as oxygen, sulfur and/or nitrogen. Preferred heterocycloalkyls are those having 3 to 6 ring atoms, such as, for example, aziridinyl, azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl. Ring systems in which optionally one or more possible double bonds may be contained in the ring are for example cycloalkenyls such as cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclopentadienyl, cyclohexenyl, cycloheptenyl, with the connection possibly taking place either at the double bond or at the single bonds. [0065] Halogen means in each case fluorine, chlorine, bromine or iodine. [0066] The C 6 -C 12 -aryl radical includes in each case 6-12 carbon atoms and may for example be benzo-fused. Examples which may be mentioned are: phenyl, tropyl, cyclooctadienyl, indenyl, naphthyl, biphenyl, fluorenyl, anthracenyl etc. [0067] The monocyclic C 5 -C 7 -heteroaryl radical, the tricyclic C 8 -C 12 -heteroaryl radical and the C 5 -C 16 -heteroaryl radical mean ring systems which comprise in each case 5-16 ring atoms and which may, instead of the carbon, comprise one or more, identical or different, heteroatoms such as oxygen, sulfur or nitrogen, and where the C 5 -C 16 -heteroaryl radical may be mono-, bi- or tricyclic and may additionally in each case be benzo-fused. [0068] Examples which may be mentioned are: [0000] thienyl, furanyl, pyrrolyl, oxazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, thiadiazolyl, etc. and benzo derivatives thereof, such as, for example, benzofuranyl, benzothienyl, benzooxazolyl, benzimdazolyl, indazolyl, indolyl, isoindolyl, etc; or pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, etc. and benzo derivatives thereof such as, for example, quinolyl, isoquinolyl, etc; or azocinyl, indolizinyl, purinyl, etc. and benzo derivatives thereof; or quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, phenoxazinyl, xanthenyl, oxepinyl, benzotriazolyl, etc. [0069] The heteroaryl radical may in each case be benzo-fused. Examples of 5-membered heteroaromatic rings which may be mentioned are: thiophene, furan, oxazole, thiazole, imidazole, pyrazole and benzo derivatives thereof, and of 6-membered heteroaromatic rings pyridine, pyrimidine, triazine, quinoline, isoquinoline and benzo derivatives. [0070] Heteroatoms mean oxygen, nitrogen or sulfur atoms. [0071] If an acidic function is present, suitable salts are the physiologically tolerated salts of organic and inorganic bases, such as, for example, the readily soluble alkali metal and alkaline earth metal salts, and N-methylglucamine, dimethylglucamine, ethylglucamine, lysine, 1,6-hexanediamine, ethanolamine, glucosamine, sarcosine, serinol, tris-hydroxymethylaminomethane, aminopropanediol, Sovak base, 1-amino-2,3,4-butanetriol. [0072] If a basic function is present, the physiologically tolerated salts of organic and inorganic acids are suitable, such as hydrochloric acid, sulfuric acid, phosphoric acid, citric acid, tartaric acid inter alia. [0073] Preference is given to those compounds of the general formula (I) [0000] where A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 4 and/or R 3 , R 1 is a hydrogen or C 1 -C 6 -alkyl radical which may be substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl radical which may be substituted one or more times by halogen, R 3 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl-, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, O—O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. [0104] Preference is likewise given to those compounds of the general formula (I) [0000] where A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 4 and/or R 3 , R 1 is a hydrogen or a C 1 -C 6 -alkyl group which is substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or a C 1 -C 6 -alkyl group which is substituted one or more times by halogen, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , SO 2 NH 2 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 6 -acyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, a C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl, which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), C 1 -C 6 -acyl, N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 or C 1 -C 6 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH-—NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. [0134] Preference is likewise given to those compounds of the general formula (I), [0000] where A is an aryl or heteroaryl radical which may optionally be substituted one or more times by R 4 and/or R 3 , R 1 is a hydrogen or a C 1 -C 6 -alkyl group which is substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl group which is substituted one or more times by halogen, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 6 -acyl-, —O—CO—NH(C 1 -C 6 -alkyl), —O—CO—N(C 1 -C 6 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 6 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted one or more times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), N—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 6 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 12 -heteroaryl which may be substituted at least one or more times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. [0164] Preference is likewise given to those compounds of the general formula (I) [0000] where A is a phenyl, naphthyl or heteroaryl radical which may optionally be substituted once or twice by R 3 and/or R 4 , R 1 is a hydrogen or a C 1 -C 6 -alkyl group which may be substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl group, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 4 -alkyl, where p is 0-2, C 1 -C 4 -acyl-, —O—CO—NH(C 1 -C 4 -alkyl), —O—CO—N(C 1 -C 4 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 4 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 6 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or by CO—N(C 1 -C 6 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 6 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m , —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. [0194] Preference is likewise given to those compounds of the general formula (I), [0000] where A is a phenyl, naphthyl or heteroaryl radical which may optionally be substituted once or twice by R 3 and/or R 4 , R 1 is a hydrogen or a C 1 -C 6 -alkyl radical which is substituted one or more times by halogen, R 2 is a hydrogen, halogen, cyano, an —S(O) q —CH 3 , where q is 0-2, a C 1 -C 4 -alkoxy radical or C 1 -C 6 -alkyl radical which is substituted one or more times by halogen, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, or if R 4 is —S(O) p —C 1 -C 4 -alkyl, where p is 0-2, C 1 -C 4 -acyl-, —O—CO—NH(C 1 -C 4 -alkyl), —O—CO—N(C 1 -C 4 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 4 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once, twice, three, four or five times, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is identically or differently a C 1 -C 4 -alkyl radical, where at least one of the radicals is substituted at least once by halogen, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or else twice, three, four or five times, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , a C 3 -C 6 -cycloalkyl which may optionally be substituted once, twice, three, four or five times, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m , —CH 2 —(CH 2 ) m —CO—, —O—(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. [0224] Preference is likewise given to those compounds of the general formula (I) [0000] where A is a phenyl, naphthyl or heteroaryl radical which may optionally be substituted once or twice by R 3 and/or R 4 , R 1 is a hydrogen or a C 1 -C 4 -alkyl radical which is substituted once, twice or three times by chlorine, fluorine, or bromine, R 2 is a hydrogen, chlorine, fluorine, bromine, cyano, an OCH 3 group or a C 1 -C 4 -alkyl radical which is substituted once, twice or three times by chlorine, fluorine or bromine, R 3 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once or twice, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is a CF 3 radical, or if R 4 is —S(O) p —C 1 -C 6 -alkyl, where p is 0-2, C 1 -C 4 -acyl-, —O—CO—NH(C 1 -C 4 -alkyl), —O—CO—N(C 1 -C 4 -alkyl) 2 , C 6 -C 12 -aryloxy, C 5 -C 16 -heteroaryloxy, hydroxy, cyano or N—(C 1 -C 4 -alkyl) 2 , a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or twice, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -alkyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 4 is a hydrogen, halogen, amino, —S(O) p —CH 3 , where p is 0-2, an —S—CF 3 , C 1 -C 6 -acyl, NH—CO—NH 2 , NH—CO—C 1 -C 6 -alkyl, —O—CO—NHCH 3 , —O—CO—N(CH 3 ) 2 , or C 1 -C 6 -alkyl group which may optionally be substituted once or twice, identically or differently, by C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , C 5 -C 12 -heteroaryl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , a C 1 -C 4 -alkoxy which may optionally be substituted one or more times, identically or differently, by hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , NH—C 3 -C 6 -cycloalkyl, COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or by CO—N(C 1 -C 4 -alkyl) 2 , an O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a CH 2 O—C 6 -C 12 -aryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , an O—C 5 -C 16 -heteroaryl which may optionally be substituted by hydroxy, cyano, COOH or CO—NH 2 , a hydroxy, cyano, O—CO—(C 1 -C 4 -alkyl), CO—NH(C 5 -C 12 -heteroaryl), NH—(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 or a C 6 -C 12 -aryl which may optionally be substituted one or more times, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryl, C 5 -C 12 -heteroaryl, hydroxy, CH 2 —OH, cyano, CH 2 —CN, amino, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , NHSO 2 CH 3 , SO 2 NH 2 , SO 2 NH(C 1 -C 6 -alkyl), SO 2 N(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl), CO—N(C 1 -C 6 -alkyl) 2 , CO—NH(C 5 -C 12 -heteroaryl), NH—CO(C 1 -C 6 -alkyl), CH 2 —NH—CO(C 1 -C 6 -alkyl), NH—CO(C 5 -C 12 -heteroaryl), CH 2 —NH—CO(C 5 -C 12 -heteroaryl), styryl, or an —S(O) r —CH 3 , where r is 0-2, or two adjacent positions may be substituted by —O—CH 2 —O— or —O—C(CH 3 ) 2 —O—, a monocyclic C 5 -C 7 -heteroaryl which may optionally be substituted one or more times, identically or differently, by C 1 -C 6 -alkyl, if R 2 is cyano or if R 1 and/or R 2 is a CF 3 radical, a monocyclic C 5 -C 7 -heteroaryl which may be substituted at least once or twice, identically or differently, by halogen, by CF 3 , C 1 -C 4 -acyl, C 1 -C 4 -alkoxy, hydroxy, CH 2 —OH, cyano, CO 2 —(C 1 -C 4 -alkyl), N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl) or CO—N(C 1 -C 4 -alkyl) 2 , or a bi- or tricyclic C 8 -C 12 -heteroaryl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 6 -alkyl, C 1 -C 6 -acyl, C 1 -C 6 -alkoxy, hydroxy, cyano, CO 2 —(C 1 -C 6 -alkyl), N—(C 1 -C 6 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 6 -alkyl) or CO—N(C 1 -C 6 -alkyl) 2 , or a C 3 -C 6 -cycloalkyl which may optionally be substituted once or twice, identically or differently, by halogen, by C 1 -C 4 -alkyl, hydroxy, cyano, CO 2 —(C 1 -C 4 -alkyl), C 1 -C 4 -acyl, N—(C 1 -C 4 -alkyl) 2 , COOH, CO—NH 2 , CO—NH(C 1 -C 4 -alkyl), CO—N(C 1 -C 4 -alkyl) 2 or C 1 -C 4 -alkoxy, R 3 and R 4 are either in ortho, meta position or meta, para position relative to one another and together have the meaning of —O—CO—S—, —S—CO—O—, CH 2 —CO—O—, O—CO—CH 2 —, —CH 2 —CO—NH—, —NH—CO—CH 2 —, —O—CO—NH—, —NH—CO—O—, —CO—CH 2 —(CH 2 ) m —, —CH 2 —(CH 2 ) m —CO—, —O(CH 2 ) m —O—, —O—C—(CH 3 ) 2 —O—, —CH 2 —(CH 2 ) m —CH 2 —, where m is 1-3, Y is a —(CH 2 ) n — group, where n is 1-3, and the isomers, diastereomers, enantiomers and salts thereof, and cyclodextrin clathrates. [0254] The following compounds corresponding to the present invention are very particularly preferred: 1. biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 2. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4,5-trimethoxybenzamide 3. 4-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 4. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methylbenzamide 5. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 6. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-trifluoromethylbenzamide 7. 3-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 8. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methoxybenzamide 9. 4-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 10. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methylbenzamide 11. 4-tert-butyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 12. benzo[1,3]dioxole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 13. thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 14. quinoxaline-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 15. 5-phenylpyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 16. 5-phenyl-1H-pyrrole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 17. N-[2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 18. (±)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methanesulfinylbenzamide 19. N-[2-(7-fluoro-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 20. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-[1,2,4]triazol-1-ylmethylbenzamide 21. thieno[2,3-b]pyrazine-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 22. N-[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 23. N-[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 24. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methanesulfonylbenzamide 25. N-[2-(4-bromo-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 26. 1H-benzotriazole-5-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 27. 1H-indole-2-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 28. 4′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 29. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-N′-pyridin-3-yl-terephthalamide 30. 4-amino-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 31. 5-bromofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 32. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-isonicotinamide 33. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 34. 2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 35. 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 36. 1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 37. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-methylnicotinamide 38. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methoxybenzamide 39. 4-ethoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 40. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxy-3,5-dimethoxy-benzamide 41. 1H-benzotriazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 42. 5-methylthiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 43. 1H-pyrrole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 44. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylaminobenzamide 45. thiophene-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 46. 6-cyano-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 47. 1H-benzoimidazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 48. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-trifluoromethylbenzamide 49. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxy-3-methoxy-benzamide 50. 4-dimethylamino-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 51. 4-cyano-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 52. isoxazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 53. 4-acetyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 54. 4-chloro-3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 55. 4-chloromethyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 56. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,5-dimethylbenzamide 57. 3,4-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 58. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-propylbenzamide 59. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-hydroxy-4-methylbenzamide 60. 2,3-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 61. 3,5-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 62. naphthalene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 63. 5-chlorothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 64. 6-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 65. 3-chloromethyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 66. 4-butoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 67. 4-acetoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 68. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methylsulfanylbenzamide 69. 4-cyano-2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 70. isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 71. isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 72. isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 73. 3,5-dichloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 74. quinoline-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 75. quinoline-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 76. 4-hydroxy-2-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 77. benzo[b]thiophene-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 78. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-hydroxybenzamide 79. pyrazine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 80. furan-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 81. quinoline-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 82. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 83. 4-benzyloxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 84. 5-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 85. 1H-indole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 86. 3-bromothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 87. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 88. 2-methylfuran-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 89. 1H-imidazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 90. 4-oxo-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 91. 4′-bromobiphenyl-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 92. 2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-iodobenzamide 93. 2,3-dihydrobenzofuran-7-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 94. 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 95. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2,5-dimethylbenzamide 96. 5-acetylthiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 97. quinoline-8-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 98. 2-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 99. 6-phenylpyrimidine-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 100. 1-methyl-1H-indole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 101. 2-pyridin-3-ylthiazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 102. 2,5-dimethyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 103. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-phenoxymethylbenzamide 104. 2,3-dihydrobenzofuran-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 105. 1H-indole-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 106. 2-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4,5-dimethoxy-benzamide 107. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-pyrrolidin-1-ylbenzamide 108. quinoline-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 109. 5-phenyl-1H-pyrazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 110. pyridazine-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 111. 5-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 112. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-pyrrol-1-ylnicotinamide 113. pyrimidine-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 114. benzo[b]thiophene-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 115. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-piperidin-1-ylbenzamide 116. pyrazolo[1,5-a]pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 117. quinoxaline-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 118. 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methoxy-benzamide 119. 3-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 120. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-phenoxbenzamide 121. thiazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 122. 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methylbenzamide 123. 3-chloro-2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-benzamide 124. 5-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 125. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 126. 5-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 127. 4-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 128. 6-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 129. 4-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 130. 4-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 131. 7-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 132. 6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 133. 6-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 134. 5-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]-amide 135. 1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 136. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 137. 5-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]-amide 138. 6-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]-amide 139. 4-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]-amide 140. 4-dimethylamino-N-[2-(7-fluoro-1H-indol-3-yl)ethyl]benzamide 141. N-[2-(7-fluoro-1H-indol-3-yl)ethyl]-4-pyrrolidin-1-ylbenzamide 142. 1H-indole-6-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 143. 4-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]-amide 144. 4-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 145. 6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 146. 6-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]-amide 147. 7-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]-amide 148. 5-bromo-2,3-dihydrobenzofuran-7-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 149. 4-(1H-benzoimidazol-2-yl)-N-[2-(7-fluoro-1H-indol-3-yl)ethyl]benzamide 150. 4-(1H-benzoimidazol-2-yl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 151. N-[2-(4-cyano-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 152. [1,1′; 4′,1″]terphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 153. 3′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 154. 3′-fluoro-4′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 155. 2′-fluoro-4′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 156. 4′-hydroxymethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 157. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-4-carboxylic acid 158. 4′-tert-butylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 159. 4′-chlorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 160. 3′,4′,5′-trimethoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 161. 3′-trifluoromethoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 162. 4′-trifluoromethoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 163. 3′-hydroxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 164. 4′-methanesulfinylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 165. 3′-cyanomethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 166. 2′-acetylaminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 167. 3′-fluoro-4′-methoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 168. 3′-chloro-4′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 169. 3′,4′-difluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 170. 3′,5′-difluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 171. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(5-hydroxymethyl-thiophen-2-yl)-benzamide 172. 3′-methanesulfonylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 173. 4-fluoro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-3-carboxylic acid 174. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-methoxy-biphenyl-4-carboxylic acid methyl ester 175. 5-fluoro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-3-carboxylic acid 176. 3-chlorobiphenyl-4,4′-dicarboxylic acid 4-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 177. 3-chlorobiphenyl-4,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}-4-methylamide 178. 3′-dimethylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 179. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-thiazol-2-ylamide 180. 4′-methylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 181. 4′-dimethylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 182. biphenyl-3,4′-dicarboxylic acid 3-diethylamide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 183. biphenyl-4,4′-dicarboxylic acid 4-diethylamide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 184. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]biphenyl-3-carboxylic acid 185. biphenyl-4,4′-dicarboxylic acid 4-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 186. 3′-methylsulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 187. 3′-trifluoromethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 188. 4′-methylsulfanylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 189. 4′-acetylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 190. 3′-aminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 191. 3′-acetylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 192. 3′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 193. [1,1′; 3′,1″]terphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 194. 3′-hydroxymethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 195. 4-benzo[b]thiophen-3-yl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 196. 4′-trifluoromethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 197. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-((E)-styryl)benzamide 198. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-quinolin-6-ylbenzamide 199. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(6-methoxypyridin-3-yl)-benzamide 200. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-methylamide 201. biphenyl-4,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}-4-methylamide 202. 2′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 203. 2′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 204. 3′-acetylaminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 205. 4-benzo[1,3]dioxol-5-yl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-benzamide 206. 3′-cyanobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 207. 4′-cyanomethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 208. biphenyl-3,4′-dicarboxylic acid 3-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 209. 3′,5′-dimethylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 210. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-quinolin-3-ylbenzamide 211. 4′-acetylaminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 212. 3′-fluoro-5′-methoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 213. 5-fluorobiphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-methylamide 214. 3′-(acetylaminomethyl)biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 215. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(1-methyl-1H-indol-5-yl)benzamide 216. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(1-methyl-1H-indol-2-yl)benzamide 217. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-pyrrol-1-ylnicotinamide 218. N-[2-(4-cyano-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 219. 5-benzyloxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 220. 5-hydroxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 221. 5-methoxybenzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 222. 6-hydroxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 223. N-[2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 224. 3H-benzotriazole-5-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 225. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 226. quinoxaline-6-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 227. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}acetic acid methyl ester 228. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}butanoic acid ethyl ester 229. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}pentanoic acid ethyl ester 230. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}hexanoic acid ethyl ester 231. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}acetic acid methyl ester 232. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}butanoic acid ethyl ester 233. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}pentanoic acid ethyl ester 234. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}hexanoic acid ethyl ester 235. 6-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 236. 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 237. 4-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 238. 6-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 239. {3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}acetic acid methyl ester 240. 4-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoic acid ethyl ester 241. 5-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoic acid ethyl ester 242. 2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}acetic acid 243. 4-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}butanoic acid 244. 5-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}pentanoic acid 245. 6-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoic acid ethyl ester 246. 5-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}pentanoic acid 247. 6-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}hexanoic acid 248. 4-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}butanoic acid 249. 6-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}hexanoic acid 250. 4-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoic acid 251. {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}acetic acid 252. 4-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoic acid ethyl ester 253. 5-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoic acid ethyl ester 254. 6-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoic acid ethyl ester 255. 6-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoic acid 256. 4-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoic acid 257. 5-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoic acid 258. 6-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoic acid 259. 5-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoic acid 260. 2-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]isonicotinamide 261. {4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}acetic acid 262. 5-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 263. 6-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 264. 5-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 265. 6-(3-carbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 266. 6-(3-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 267. 6-(3-hydroxyphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 268. 4-(3-carbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 269. 4-(3-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 270. 4-(3-hydroxyphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 271. 4-(4-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 272. 5-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 273. benzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 274. 5-chloro-benzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 275. 4-bromo-3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-benzamide 276. 4-chloro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-3-carboxylic acid 277. {3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}acetic acid 278. 5-(3-carbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 279. 5-(3-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 280. 5-(3-hydroxyphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 281. 6-(3-carbamoylphenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-nicotinamide 282. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(3-methylcarbamoyl-phenyl)nicotinamide 283. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(3-hydroxyphenyl)-nicotinamide 284. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(4-methylcarbamoyl-phenyl)nicotinamide 285. 5-(3-carbamoylphenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-nicotinamide 286. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(3-methylcarbamoyl-phenyl)nicotinamide 287. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(3-hydroxyphenyl)-nicotinamide 288. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(4-methylcarbamoyl-phenyl)nicotinamide 289. 2-(3-carbamoylphenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-isonicotinamide 290. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-(3-methylcarbamoyl-phenyl)isonicotinamide 291. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-(3-hydroxyphenyl)-isonicotinamide 292. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-(4-methylcarbamoyl-phenyl)isonicotinamide 293. benzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 294. quinoline-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 295. [1,8]naphthyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 296. isoquinoline-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 297. 5-pyridin-2-yl-thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 298. 5-trifluoromethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 299. 5-fluoro-1H-indole-2-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 300. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 301. 6-(3-trifluoromethoxyphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 302. 5-(4-methylcarbamoylphenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 303. 4′-methoxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 304. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-methoxybiphenyl-4-carboxylic acid 305. 4′-methoxybiphenyl-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 306. 4-(4-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 307. 4-(3-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 308. 4-(3-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 309. 4-(3-hydroxyphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 310. 4-(3-carbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 311. 4-bromothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 312. 2-fluorobiphenyl-4,4′-dicarboxylic acid 4-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}-4′-methylamide 313. 2′-fluorobiphenyl-3,4′-dicarboxylic acid 3-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 314. 2-fluoro-3′-hydroxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 315. 2′-fluorobiphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide}3-methylamide 316. 5-(3-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 317. 5-bromothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 318. 3′-hydroxybiphenyl-4-carboxylic acid [2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 319. biphenyl-4,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}4-methylamide 320. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-hydroxybiphenyl-4-carboxylic acid methyl ester 321. N-[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-6-(3-methylcarbamoylphenyl)-nicotinamide 322. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 323. 5-(3-carbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 324. 5-(3-hydroxyphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 325. 5-(4-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 326. 5-(3-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 327. 5-(3-carbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 328. 5-(3-hydroxyphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 329. 5-(4-methylcarbamoylphenyl)thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 330. 6-(3-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 331. 6-(3-carbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 332. 6-(3-hydroxyphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 333. 6-(4-methylcarbamoylphenyl)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 334. 3′-cyano-2′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 335. 5-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 336. 5-chloro-1H-indole-2-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 337. 5-chloro-1H-indole-2-carboxylic acid [2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 338. 5-trifluoromethyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 339. 6-methanesulfonyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 340. 7-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 341. 4-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 342. 6-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 343. 7-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 344. 5-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 345. 5-trifluoromethyl-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 346. 5-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 347. 5-trifluoromethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]amide 348. N-[2-(7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide 349. biphenyl-3,4′-dicarboxylic acid 4′-{[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 350. 5-fluoro-1H-indole-2-carboxylic acid [2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 351. 5-trifluoromethoxy-1H-indole-2-carboxylic acid [2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 352. 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-hydroxybiphenyl-4-carboxylic acid 353. 4-bromo-N-[2-(4-fluoro-2,7-dimethyl-1H-indol-3-yl)ethyl]benzamide 354. 4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 355. N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxybenzamide 356. 3′-(2,5-dioxoimidazolidin-4-yl)biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 357. 3-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 358. 5-bromobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 359. 6-bromobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 360. 6-trifluoromethylbenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361. 6-trifluoromethoxybenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 362. 5-trifluoromethoxybenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 363. benzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 364. 5-chlorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 365. 6-chlorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 366. 5-fluorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 367. 6-fluorobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 368. 5-trifluoromethylbenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 369. 6-trifluoromethylbenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 370. 5-trifluoromethoxybenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 371. 6-trifluoromethoxybenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 372. 5-bromobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 373. 6-bromobenzothiazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 374. benzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 375. 5-chlorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 376. 6-chlorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 377. 5-fluorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 378. 6-fluorobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 379. 5-trifluoromethylbenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 380. 6-trifluoromethylbenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 381. 5-trifluoromethoxybenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 382. 6-trifluoromethoxybenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 383. 5-bromobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 384. 6-bromobenzoxazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 385. 1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 386. 5-chloro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 387. 6-chloro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 388. 5-fluoro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 389. 6-fluoro-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 390. 5-trifluoromethyl-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 391. 6-trifluoromethyl-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 392. 5-trifluoromethoxy-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 393. 6-trifluoromethoxy-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 394. 5-bromo-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 395. 6-bromo-1H-benzimidazole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 396. 5-trifluoromethylsulfanyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 397. 5,6-dichloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 398. 5-chloro-6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 399. 5-fluoro-6-chloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 400. 5,6-difluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 401. 4,6-dichloro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 402. 4,6-difluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 403. 5-acetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 404. 6-acetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 405. 5-(2,2-dimethylpropionylamino)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 406. 6-(2,2-dimethylpropionylamino)-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 407. 5-trifluoroacetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 408. 6-trifluoroacetylamino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 409. 5-isopropyloxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 410. 6-isopropyloxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 411. 5-isopropyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 412. 6-trifluoromethyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 413. 4,5,6,7-tetrahydro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 414. 3-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 415. 5-trifluoromethylbenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 416. 5-fluorobenzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 417. 5-amino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 418. 6-amino-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 419. 6-dimethylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 420. 5-dimethylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 421. 6-methylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 422. 5-methylcarbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 423. 6-carbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 424. 5-carbamoylmethoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 425. 6-tert-butyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 426. 5-tert-butyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0681] The present invention relates to the use of the compounds of the invention for manufacturing medicaments which comprise at least one of the compounds of formula I. [0682] The present invention likewise relates to medicaments which comprise the compounds of the invention with suitable formulating substances and carriers. [0683] Compared with known prostaglandin E 2 ligands, the novel EP 2 agonists and antagonists are distinguished by greater selectivity and stability. [0684] The present invention relates to medicaments for the treatment and prophylaxis of disorders which include fertility impairments, infectious disorders, cancer, viral infections, cardiovascular disorders, elevated intraocular pressure, glaucoma, skeletal system disorders, angiogenetic disorders, uterine contraction impairments, pain, neuroinflammatory disorders, immunomodulatory infections and nephrological disorders. [0685] Fertility impairments mean the disorders which lead to no ovulation taking place, that no nidation of a fertilized oocyte occurs and no decidualization takes place, infectious disorders mean disorders caused by unicellular parasites, cancer means solid tumors and leukemia, viral infections mean for example cytomegalievirus infections, hepatitis, hepatitis B and C and HIV disorders, immunomodulatory infections mean for example avian influenza, cardiovascular disorders mean ischemic reperfusion disorder, stenoses, arterioscleroses and restenoses, angiogenetic disorders mean for example endometriosis and fibrosis, elevated intraocular pressure means glaucoma, uterine contraction impairments mean for example painful menstruation, skeletal system disorders mean osteoporosis, neuroinflammatory disorders mean multiple sclerosis, Alzheimer's disease, pain and nephrological disorders mean glomerulonephritis. [0686] The present invention likewise relates to medicaments for the treatment and prophylaxis of the disorders detailed above, which comprise at least one compound of the general formula I, and medicaments with suitable formulating substances and carriers. [0687] For the compounds of the invention to be used as medicaments they are brought into the form of a pharmaceutical product which, besides the active ingredient, comprises inert organic or inorganic pharmaceutical carrier materials which are suitable for enteral or parenteral administration, such as, for example, water, gelatin, gum arabic, lactose, starch, magnesium stearate, talc, vegetable oils, polyalkylene glycols etc. The pharmaceutical products may be in solid form, for example as tablets, coated tablets, suppositories, capsules, in semisolid form, for example as ointments, creams, gels, suppositiories, emulsions or in liquid form, for example as solutions, suspensions or emulsions. [0688] They comprise where appropriate excipients which are intended to act for example as fillers, binders, disintegrants, lubricants, solvents, solubilizers, masking flavors, colorant, emulsifiers. Examples of types of excipients for the purpose of the invention are saccharides (mono-, di-, tri-, oligo-, and/or polysaccharides), fats, waxes, oils, hydrocarbons, anionic, nonionic, cationic natural, synthetic or semisynthetic surfactants. They additionally comprise where appropriate excipients such as preservatives, stabilizers, wetting agents or emulsifiers; salts to modify the osmotic pressure or buffers. The present invention likewise relates to these pharmaceutical products. [0689] It is expedient to produce aerosol solutions for inhalation. [0690] Suitable for oral use are in particular tablets, coated tablets or capsules with talc and/or hydrocarbon carriers or binders, such as, for example, lactose, corn starch or potato starch. Use can also take place in liquid form, such as, for example, as solution to which, where appropriate, a sweetener is added. Clathrates are likewise also suitable for oral use of such compounds, examples of clathrates which may be mentioned being those with alpha-, beta-, gamma-cyclodextrin or else beta-hydroxypropylcyclodextrin. [0691] Sterile, injectable, aqueous or oily solutions are used for parenteral administration. Particularly suitable are injection solutions or suspensions, especially aqueous solutions of active compounds in polyethoxylated castor oil. [0692] Examples suitable and customary for vaginal administration are pessaries, tampons or intrauterine device. [0693] Appropriately prepared crystal suspensions can be used for intraarticular injection. [0694] It is possible to use for intramuscular injection aqueous and oily injection solutions or suspensions and appropriate depot preparations. [0695] For rectal administration, the novel compounds can be used in the form of suppositories, capsules, solutions (e.g. in the form of enemas) and ointments both for systemic and for local therapy. [0696] The novel compounds can be used in the form of aerosols and inhalations for pulmonary administration. [0697] For local use on the eyes, external auditory canal, middle ear, nasal cavity and paranasal sinuses, the novel compounds can be used as drops, ointments and tinctures in appropriate pharmaceutical preparations. [0698] Formulations possible for topical application are gels, ointments, fatty ointments, creams, pastes, dusting powders, milk and tinctures. The dosage of the compounds of the general formula I should in these preparations be 0.01%-20% in order to achieve an adequate pharmacological effect. [0699] The dosage of the active ingredients may vary depending on the route of administration, age and weight of the patient, nature and severity of the disorder to be treated and similar factors. Treatment can take place by single dosages or by a large number of dosages over a prolonged period. The daily dose is 0.5-1000 mg, preferably 50-200 mg, it being possible to give the dose as a single dose to be administered once or divided into 2 or more daily doses. [0700] Carrier systems which can be used are also surface-active excipients such as salts of bile acids or animal or vegetable phospholipids, but also mixtures thereof, and liposomes or constituents thereof. [0701] The present invention likewise relates to the formulations and dosage forms described above. [0702] Administration of the compounds of the invention can take place by any conventional method, including oral and parenteral, e.g. by subcutaneous or intramuscular injections. The present invention likewise relates to enteral, parenteral, vaginal and oral administrations. [0703] The compounds of the invention of the general formula I bind to the EP 2 receptor and have agonistic or antagonistic effect. It is possible to determine whether an agonistic or an antagonistic effect is present by an agonism test (see Example 1.2.1. of the Biological Examples) or by an antagonism test (see Example 1.2.2. of the Biological Examples). [0704] Antagonists mean molecules which bind to their corresponding receptors and which inhibit the initiation of the signal transduction pathway(s) coupled to the receptor by the naturally occurring ligand(s). The antagonists normally compete with the naturally occurring ligand of the receptor for binding to the receptor. However, other modifications of the receptor are also possible by molecules which prevent the signal transduction pathways coupled to the receptor being activated by the naturally occurring ligand(s) (e.g. non-competitive, steric modifications of the receptor). [0705] Receptor antagonists typically bind selectively to their particular receptor and not to other receptors. They normally have a higher binding affinity than the natural ligand. Although antagonists which have a higher affinity for the receptor than the natural ligand are preferred, it is likewise possible to employ antagonists having a lower affinity. [0706] The antagonists preferably bind reversibly to their corresponding receptors. [0707] The EP 2 receptor antagonist has a preferred affinity for the EP 2 receptor compared with any other EP receptor. The antagonism is measured in the presence of the natural agonist (PGE 2 ). [0708] Agonists mean molecules which bind to their corresponding receptors and normally compete with the naturally occurring ligand of the receptor for binding to the receptor, and which stimulate the initiation of the signal transduction pathway coupled to the receptor. Agonists may also assist the binding of the natural ligand. [0709] Receptor agonists typically bind selectively to their particular receptor and not to other receptors. They normally have a higher binding affinity than the natural ligand. Although agonists which have a higher affinity for the receptor than the natural ligand are preferred, it is likewise possible to employ agonists having a lower affinity. [0710] The agonists preferably bind reversibly to their corresponding receptors. [0711] The EP 2 receptor agonist has a preferred affinity for the EP 2 receptor compared with any other EP receptor. [0712] Agonists are tested via the initiation of the signal transduction and/or physiological effect mediated by the corresponding receptor. [0713] The compounds or low molecular weight substances which bind to a receptor are referred to as ligands. Their binding is normally reversible. Binding of a ligand to the corresponding receptor activates or inactivates the signal transduction pathway coupled to the receptor. The ligand mediates its intracellular effect in this manner. Ligands mean agonists and antagonists of a receptor. [0714] The substance of Example 29 shows no inhibition in the cellular agonism test but a good activity (IC 50 =1.2×10 E-6 M) in the antagonism test. The present invention likewise relates to the use of the substances of the invention as EP 2 receptor antagonists for the treatment of disorders which are caused by disturbances in the signal transduction chain in which the EP 2 receptor is involved, such as, for example, pain and fertility impairments, and which are likewise suitable for controlling fertility. [0715] The oocyte is surrounded in the preovulatory antral follicle by cumulus cells which form a dense ring of cells around the oocyte. After the lutenizing hormone peak (LH peak), a series of processes is activated and leads to a large morphological change in this ring of cells composed of cumulus cells. In this case, the cumulus cells form an extracellular matrix which leads to so-called cumulus expansion (Vanderhyden et al. Dev Biol. 1990 August; 140(2):307-317). This cumulus expansion is an important constituent of the ovulatory process and of the subsequent possibility of fertilization. [0716] Prostaglandins, and here prostaglandin E 2 , whose synthesis is induced by the LH peak, are of crucial importance in cumulus expansion. Prostanoid EP 2 knockout mice (Hizaki et al. Proc Natl Acad Sci USA. 1999 Aug. 31; 96(18): 10501-6.) show a distinctly reduced cumulus expansion and severe subfertility, demonstrating the importance of the prostanoid EP 2 receptor for this process. [0717] The substances of the invention have inhibitory effects in cumulus expansion tests. [0718] The present invention relates to the use of the substances of the invention for controlling fertility. [0719] Whereas the EP 2 receptor antagonist AH 6809 inhibits cumulus expansion by about only 30% and not until the concentration is 100-200 μM, an about 20% inhibition of cumulus expansion can be achieved in the presence of the substance of Example 29 even at a concentration which is 10-20 times lower (10 μM). In these experiments, the test substances compete with the natural EP 2 receptor agonist PGE 2 . [0720] The present invention relates to the use of the substances of the invention for inhibiting cumulus expansion and thus ovulation and fertilization for contraception. [0721] Prostaglandins play an important part in angiogenesis (Sales, Jabbour, 2003, Reproduction 126, 559-567; Kuwano et al., 2004, FASEB J. 18, 300-310; Kamiyama et al., 2006, Oncogene 25, 7019-7028; Chang et al. 2005, Prostaglandins & other Lipid Mediators 76, 48-58). [0722] Endometriosis is a chronic disorder caused by impairments of blood vessels. About 10% of women regularly suffer from heavy bleeding during menstruation, caused by changes in the blood vessels of the endometrium. In addition, structural differences in the blood vessels have been observed, such as, for example, incomplete formation of the smooth muscle cell layer (Abberton et al., 1999, Hum. Reprod. 14, 1072-1079). Since the blood loss during menstruation is partly controlled by constriction of the blood vessels, it is obvious that the defects in the smooth muscles make a substantial contribution to the bleeding. [0723] The present invention relates to the use of the substances of the general formula I for treating endometriosis. [0724] Prostaglandins play an important part in uterine contraction, and excessively strong contractions are responsible for painful menstruation (Sales, Jabbour, 2003, Reproduction 126, 559-567). [0725] The present invention relates to the use of the substances of the general formula I for the treatment of painful menstruation. [0726] Increasing research results also demonstrate the importance of EP receptors, and especially of the EP 2 receptor, in a large number of types of cancer (e.g. breast cancer, colon carcinoma, lung cancer, prostate cancer, leukemia, skin cancer), suggesting future possibilities of employing modulators (antagonists or agonists) of the EP2 receptor for the therapy and prevention (prophylactic and/or adjuvant) of cancer (Fulton et al. Cancer Res 2006; 66(20): 9794-7; Castellone et al. Science VOL 310 2005, 1504-1510; Chang et al. Cancer Res 2005; 65(11): 4496-9); Hull et al. Mol Cancer Ther 2004; 3(8): 1031-9; Richards et al. J Clin Endocrinol Metab 88: 2810-2816, 2003; Sinha et al. 2007, Cancer Res; 67(9):4507-13; Wang et al. 2004, Seminars in Oncology, Vol 31, No 1, Suppl 3: pp 64-73). [0727] The present invention relates to the use of the substances of the general formula I for the treatment and prevention of cancers. [0728] Prostaglandins also play an important part in processes counteracting osteoporosis. The present invention therefore relates to the use of the substances of the invention for the treatment of osteoporosis. Reinold et al. (J. Clin. Invest. 115, 673-679 (2005)) describes PGE 2 receptors of the EP 2 subtype as the key signaling elements in inflammatory hyperalgesia. Mice no longer having this receptor (EP 2 −/−) do not experience spinal inflammatory pain. There is evidence that an inflammatory, increased pain sensitivity can be treated by targeted modulation of EP 2 receptors. [0729] The present invention relates to the use of the substances of the invention for the treatment of inflammatory hyperalgesia. [0730] The invention additionally relates to a process for preparing the compounds of the invention of the general formula I, which comprises reacting a compound of the formula II [0000] [0000] in which R 1 , R 2 and Y have the meanings indicated above, with a carboxylic acid derivative of the general formula III [0000] [0000] in which A, R 3 and R 4 have the meanings indicated above, and R 5 may be a hydroxy group, a chlorine or bromine atom or a C 1 -C 6 -alkyl radical, with preference for hydrogen, chlorine, the methyl or ethyl radical, by methods known to the skilled worker, and subsequently eliminating protective groups required where appropriate. [0731] In the case where R 5 is a hydroxy group, the reaction can initially take place by activating the acid function, and in this case for example the carboxylic acid of the formula III is initially converted in the presence of a tertiary amine such as, for example, triethylamine with isobutyl chloroformate into the mixed anhydride. Reaction of the mixed anhydride with the alkali metal salt of the appropriate amine takes place in an inert solvent or solvent mixture such as, for example, tetrahydrofuran, dimethoxyethane, dimethylformamide, hexamethylphosphoric triamide, at temperatures between −30° C. and +60° C., preferably at 0° C. to 30° C. [0732] A further possibility is to activate the carboxylic acid by reagents such as, for example, HOBt or HATU. Reaction of the acid takes place for example with HATU in an inert solvent such as, for example, DMF in the presence of the appropriate amine of the general formula III and a tertiary amine such as, for example, ethyldiisopropylamine at temperatures between −50 and +60° C., preferably at 0° C. to 30° C. [0733] In the case where R 5 is C 1 -C 6 -alkyl it is also possible for example to carry out a direct amidolysis of the ester with the appropriate amine, possibly with the assistance of trialkylaluminum reagents, preferably trimethylaluminum. [0734] In the case where R 5 is a chlorine or bromine atom it is possible for example to carry out the reaction for example in pyridine or an inert solvent such as, for example, DMF in the presence of the appropriate amine of the general formula II and a tertiary amine such as, for example, ethyldiisopropylamine at temperatures between −50 and +60° C., preferably at 0° C. to 30° C. [0735] It is possible where appropriate for the compounds of the general formula (I) with R 2 ═CN also to be prepared starting from the corresponding halides, preferably bromine or chlorine, by a Cu- or Pd-catalyzed (e.g. Pd(OAc) 2 ) cyanide introduction with Zn(CN) 2 or else K 3 [Fe(CN) 6 ] in an inert solvent such as dimethylacetamide, dimethylformamide or N-methylpyrrolidone at temperatures between 60° C. and the boiling point of the respective solvent. [0736] It is possible where appropriate for the compounds of the general formula (I) with R 3 or R 4 =aryl or heteroaryl, which may where appropriate be substituted by the radicals indicated previously, to be prepared starting from an appropriate halide, preferably bromine or chlorine, by a Pd-catalyzed (e.g. Pd(OAc) 2 , Pd(PPh 3 ) 4 , Pd 2 (dba) 3 , PdCl 2 (dppf)) reaction in the presence of a base such as, for example, sodium carbonate, cesium carbonate, potassium phosphate or ethyldiisopropylamine with an appropriate aryl- or heteroarylboronic acid or boronic acid derivative in a solvent such as, for example, toluene, dioxane, dimethylacetamide, dimethylformamide or N-methylpyrrolidone at temperatures between 60° C. and the boiling point of the respective solvent. [0737] The compounds of the general formula II which serve as starting materials are either known or can be prepared for example by reacting in a manner known per se the known hydrazines IV, where appropriate prepared from the corresponding known anilines by nitrosation followed by a reduction, [0000] [0000] in which R 2 has the meaning indicated above, a) with a ketone of the general formula V in which R 1 and Y have the meaning indicated above, and n=2 and 3, in a Fischer indole cyclization [0000] [0000] b) with an enol ether of the general formula VI in which R 1 and Y have the meaning indicated above, and n=2 and 3, in a Fischer indole cyclization (Org. Lett. 2004, 79ff), [0000] [0000] and converting the subsequently obtained alcohol by methods known to the skilled worker by conversion into a leaving group such as tosylate, mesylate, trifluoromesylate, chloride, bromide or iodide and subsequent reaction with, for example, sodium azide followed by a hydrolysis with PPh 3 /H 2 O in tetrahydrofuran into the amino function, or c) with a keto ester of the general formula VII in the case of Y with n=1 [0000] [0000] in which R 1 has the meaning indicated above, and R 6 is a C 1 -C 6 -alkyl radical, in a Fischer indole cyclization, and subsequently reducing the resulting ester by methods known to the skilled worker such as, for example, diisobutylaluminum hydride in an inert solvent at temperatures between −50 and 25° C., preferably between −30 and 0° C., to the corresponding alcohol which is in turn converted into the amino function by conversion into a leaving group such as tosylate, mesylate, trifluoromesylate, chloride, bromide or iodide and subsequent reaction with, for example, sodium azide, followed by a hydrolysis with PPh 3 /H 2 O in tetrahydrofuran. [0738] It is possible where appropriate for the compounds of the general formula (I) with R 2 ═CN also to be prepared starting from the corresponding halides, preferably bromine or chlorine, by a Cu- or Pd-catalyzed (e.g. Pd(OAc) 2 ) cyanide introduction with Zn(CN) 2 or else K 3 [Fe(CN) 6 ] in an inert solvent such as dimethylacetamide, dimethylformamide or N-methylpyrrolidone at temperatures between 60° C. and the boiling point of the respective solvent. Preparation of the Compounds of the Invention [0739] The following examples illustrate the preparation of the compounds of the invention of the general formula (I) without restricting the scope of the claimed compounds to these examples. [0740] The compounds of the invention of the general formula (I) can be prepared as described below. EXAMPLE 1 Biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0741] [0742] 0.10 ml of triethylamine is added to a solution of 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride in 2.1 ml of dimethylformamide, and the mixture is stirred at 25° C. for 10 minutes. Then, at this temperature, 61.9 mg of biphenyl-4-carbonyl chloride are added, and the mixture is stirred at 25° C. for a further 45 minutes. The reaction solution is then added to ice-water and extracted twice with ethyl acetate. The combined organic phases are washed twice with water, dried over sodium sulfate and, after filtration, concentrated in vacuo. The residue obtained in this way is purified by medium pressure chromatography on silica gel with hexane/0-100% ethyl acetate. 72 g of the title compound are obtained in this way. [0743] NMR (300 MHz, DMSO-d6): δ=2.30 (3H), 2.93 (3H), 2.98 (2H), 3.36 (2H), 6.54-6.68 (2H), 7.37 (1H), 7.46 (2H), 7.67-7.78 (4H), 7.92 (2H), 8.67 (1H), 11.10 (1H). EXAMPLE 2 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4,5-trimethoxybenzamide [0744] [0745] 34 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 65.9 mg of 3,4,5-trimethoxybenzoyl chloride. [0746] NMR (300 MHz, DMSO-d6): δ=2.30 (3H), 2.60 (3H), 2.95 (2H), 3.33 (2H), 3.67 (3H), 3.79 (6H), 6.54-6.67 (2H), 7.15 (2H), 8.55 (1H), 11.11 (1H). EXAMPLE 3 4-Fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide [0747] [0748] 87 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 33.3 μl of 4-fluorobenzoyl chloride. [0749] NMR (300 MHz, DMSO-d6): δ=2.28 (3H), 2.58 (3H), 2.95 (2H), 3.33 (2H), 6.53-6.65 (2H), 7.26 (2H), 7.88 (2H), 8.63 (1H), 11.10 (1H). EXAMPLE 4 4-Methyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide [0750] [0751] 41 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 37.8 μl of 4-methylbenzoyl chloride. [0752] NMR (300 MHz, DMSO-d6): δ=2.28 (3H), 2.32 (3H), 2.58 (3H), 2.94 (2H), 3.32 (2H), 6.53-6.65 (2H), 7.23 (2H), 7.72 (2H), 8.52 (1H), 11.09 (1H). EXAMPLE 5 2-Chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide [0753] [0754] 89 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 36.2 μl of 2-chlorobenzoyl chloride. [0755] NMR (300 MHz, DMSO-d6): δ=2.32 (3H), 2.57 (3H), 2.96 (2H), 3.29 (2H), 6.53-6.66 (2H), 7.32-7.43 (3H), 7.46 (1H), 8.53 (1H), 11.12 (1H). EXAMPLE 6 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-trifluoromethylbenzamide [0756] [0757] 96 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 42.5 μl of 4-trifluoromethylbenzoyl chloride. [0758] NMR (300 MHz, DMSO-d6): δ=2.28 (3H), 2.59 (3H), 2.97 (2H), 3.36 (2H), 6.53-6.66 (2H), 7.82 (2H), 8.01 (2H), 8.85 (1H), 11.11 (1H). EXAMPLE 7 3-Chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide [0759] [0760] 76 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 36.7 μl of 3-chlorobenzoyl chloride. [0761] NMR (300 MHz, DMSO-d6): δ=2.32 (3H), 2.63 (3H), 2.99 (2H), 3.37 (2H), 6.56-6.71 (2H), 7.52 (1H), 7.62 (1H), 7.83 (1H), 7.90 (1H), 8.80 (1H), 11.17 (1H). EXAMPLE 8 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methoxybenzamide [0762] [0763] 78 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 48.1 mg of 4-methoxybenzoyl chloride. [0764] NMR (300 MHz, DMSO-d6): δ=2.27 (3H), 2.58 (3H), 2.93 (2H), 3.31 (2H), 3.77 (3H), 6.53-6.66 (2H), 6.95 (2H), 7.79 (2H), 8.47 (1H), 11.11 (1H). EXAMPLE 9 4-Chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide [0765] [0766] 39 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 36.3 μl of 4-chlorobenzoyl chloride. [0767] NMR (300 MHz, DMSO-d6): δ=2.27 (3H), 2.58 (3H), 2.94 (2H), 3.32 (2H), 6.53-6.66 (2H), 7.51 (2H), 7.83 (2H), 8.72 (1H), 11.12 (1H). EXAMPLE 10 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methylbenzamide [0768] [0769] 68 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 37.6 μl of 3-methylbenzoyl chloride. [0770] NMR (300 MHz, DMSO-d6): δ=2.33 (3H), 2.37 (3H), 2.63 (3H), 2.99 (2H), 3.36 (2H), 6.54-6.72 (2H), 7.31-7.40 (2H), 7.61-7.71 (2H), 8.61 (1H), 11.16 (1H). EXAMPLE 11 4-tert-Butyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide [0771] [0772] 72 mg of the title compound are obtained in analogy to Example 1 from 70.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 52.4 μl of 4-tert-butylbenzoyl chloride. [0773] NMR (300 MHz, DMSO-d6): δ=1.26 (9H), 2.28 (3H), 2.58 (3H), 2.94 (2H), 3.32 (2H), 6.52-6.67 (2H), 7.43 (2H), 7.74 (2H), 8.54 (1H), 11.11 (1H). EXAMPLE 12 Benzo[1,3]dioxole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0774] [0775] 172 mg of N—[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethanaminium hexafluorophosphate N-oxide (HATU) and 100 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride are added to a solution of 68.4 mg of benzo[1,3]dioxole-5-carboxylic acid in 3 ml of dimethylformamide. Then, at 0° C., 0.15 ml of ethyldiisopropylamine is added dropwise, and the mixture is stirred at 25° C. for 20 hours. Then 40 ml of a mixture of ice and conc. aqueous bicarbonate solution are added, and the mixture is extracted three times with ethyl acetate. The combined organic phases are washed once with saturated sodium chloride solution, dried over sodium sulfate and, after filtration, concentrated in vacuo. The residue obtained in this way is purified by medium pressure chromatography on silica gel with hexane/0-100% ethyl acetate. 122 mg of the title compound are obtained in this way. [0776] NMR (300 MHz, DMSO-d6): δ=2.27 (3H), 2.58 (3H), 2.92 (2H), 3.30 (2H), 6.06 (2H), 6.52-6.66 (2H), 6.95 (1H), 7.34 (1H), 7.41 (1H), 8.47 (1H), 11.11 (1H). EXAMPLE 13 Thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0777] [0778] 92 mg of the title compound are obtained in analogy to Example 1 from 75.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 33.0 μl of 2-thiophenecarbonyl chloride. [0779] NMR (300 MHz, DMSO-d6): δ=2.27 (3H), 2.58 (3H), 2.93 (2H), 3.29 (2H), 6.53-6.67 (2H), 7.11 (1H), 7.68 (1H), 7.70 (1H), 8.64 (1H), 11.13 (1H). EXAMPLE 14 Quinoxaline-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0780] [0781] 67 mg of the title compound are obtained in analogy to Example 12 from 75.0 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 59.5 mg of quinoxaline-6-carboxylic acid. [0782] NMR (300 MHz, DMSO-d6): δ=2.30 (3H), 2.61 (3H), 3.01 (2H), 3.41 (2H), 6.54-6.68 (2H), 8.15 (1H), 8.26 (1H), 8.57 (1H), 9.00 (2H), 9.07 (1H), 11.15 (1H). EXAMPLE 15 5-Phenylpyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0783] [0784] 91 mg of the title compound are obtained in analogy to Example 12 from 100 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 90.3 mg of 5-phenylpyridine-2-carboxylic acid. [0785] NMR (300 MHz, DMSO-d6): δ=2.27 (3H), 2.65 (3H), 2.81 (2H), 3.20 (2H), 6.50-6.65 (2H), 7.28-7.39 (5H), 7.53 (1H), 7.81 (1H), 8.54 (1H), 8.65 (1H), 11.12 (1H). EXAMPLE 16 5-Phenyl-1H-pyrrole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0786] [0787] 74 mg of the title compound are obtained in analogy to Example 12 from 100 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 84.8 mg of 5-phenyl-1H-pyrrole-2-carboxylic acid. [0788] NMR (300 MHz, DMSO-d6): δ=2.30 (3H), 2.69 (3H), 2.95 (2H), 3.29 (2H), 6.51-6.68 (2H), 6.77 (1H), 7.17 (1H), 7.32 (2H), 7.77 (2H), 7.91 (1H) 8.23 (1H), 11.13 (1H). EXAMPLE 17 N-[2-(4,7-Difluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide [0789] [0790] 60 mg of the title compound are obtained in analogy to Example 1 from 100 mg of 2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethylamine and 143 mg of 3,4-dimethoxybenzoyl chloride. [0791] NMR (300 MHz, DMSO-d6): δ=2.24 (3H), 2.88 (2H), 3.37 (2H), 3.74 (3H), 3.76 (3H), 6.60 (1H), 6.72 (1H), 6.96 (1H), 7.37 (1H), 7.40 (1H), 8.38 (1H), 11.43 (1H). [0792] The starting material for the above title compound is prepared as follows: 17a) 2-(4,7-Difluoro-2-methyl-1H-indol-3-yl)ethylamine [0793] [0794] 2.0 g of 2,5-difluorophenylhydrazine are dissolved in 45 ml of a mixture of ethanol and water in the ratio 14:1 at 120° C. Then, when boiling, 1.59 ml of 5-chloro-2-pentanone dissolved in 2 ml of ethanol are added, and the mixture is stirred at this temperature for 16 hours. Cooling is followed by concentration in vacuo, and the resulting residue is purified by column chromatography on silica gel with methylene chloride/0-20% methanol/0.5% triethylamine. 516 mg of the title compound are obtained in this way. [0795] NMR (300 MHz, DMSO-d6): δ=2.31 (3H), 2.85 (4H), 6.61 (1H), 6.74 (1H), 11.56 (1H). EXAMPLE 18 (±)-N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methanesulfinylbenzamide [0796] [0797] 61 mg of the title compound are obtained in analogy to Example 12 from 100 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 83.5 mg of (±)-4-methanesulfinylbenzoic acid. [0798] NMR (300 MHz, DMSO-d6): δ=2.28 (3H), 2.59 (3H), 2.75 (3H), 2.96 (2H), 3.34 (2H), 6.52-6.68 (2H), 7.74 (2H), 7.98 (2H), 8.79 (1H), 11.12 (1H). EXAMPLE 19 N-[2-(7-Fluoro-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide [0799] [0800] 128 mg of the title compound are obtained in analogy to Example 12 from 100 mg of 2-(7-fluoro-1H-indol-3-yl)ethylamine and 113 mg of 3,4-dimethoxy-benzoic acid. [0801] NMR (300 MHz, DMSO-d6): δ=2.91 (2H), 3.49 (2H), 3.76 (6H), 6.85 (1H), 6.91 (1H), 6.97 (1H), 7.20 (1H), 7.38 (1H), 7.39 (1H), 7.43 (1H), 8.44 (1H), 11.27 (1H). EXAMPLE 20 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-[1,2,4]triazol-1-ylmethylbenzamide [0802] [0803] 52 mg of the title compound are obtained in analogy to Example 12 from 100 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 83.7 mg of 3-[1,2,4]triazol-1-ylmethylbenzoic acid. [0804] NMR (300 MHz, DMSO-d6): δ=2.27 (3H), 2.65 (3H), 2.94 (2H), 3.32 (2H), 5.44 (2H), 6.52-6.67 (2H), 7.34-7.47 (2H), 7.71-7.78 (2H), 7.97 (1H), 8.65 (1H), 8.66 (1H), 11.12 (1H). EXAMPLE 21 Thieno[2,3-b]pyrazine-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0805] [0806] 55 mg of the title compound are obtained in analogy to Example 12 from 100 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 74.2 mg of thieno[2,3-b]pyrazine-6-carboxylic acid. [0807] NMR (300 MHz, DMSO-d6): δ=2.29 (3H), 2.59 (3H), 2.99 (2H), 3.39 (2H), 6.53-6.69 (2H), 8.20 (1H), 8.68 (1H), 8.79 (1H), 9.20 (1H), 11.16 (1H). EXAMPLE 22 N-[2-(7-Fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide [0808] [0809] 69 mg of the title compound are obtained in analogy to Example 1 from 79 mg of 2-(7-fluoro-2-methyl-1H-indol-3-yl)ethylamine and 123 mg of 3,4-dimethoxy-benzoyl chloride. [0810] NMR (300 MHz, DMSO-d6): δ=2.28 (3H), 2.83 (2H), 3.35 (2H), 3.75 (3H), 3.76 (3H), 6.76 (1H), 6.85 (1H), 6.97 (1H), 7.27 (1H), 7.38 (1H), 7.41 (1H), 8.42 (1H), 11.13 (1H). EXAMPLE 23 N-[2-(4-Bromo-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide [0811] [0812] 38 mg of the title compound are obtained in analogy to Example 1 from 100 mg of 2-(4-bromo-7-fluoro-2-methyl-1H-indol-3-yl)ethylamine and 111 mg of 3,4-dimethoxybenzoyl chloride. [0813] NMR (300 MHz, DMSO-d6): δ=2.26 (3H), 3.06 (2H), 3.42 (2H), 3.75 (3H), 3.76 (3H), 6.74 (1H), 6.96 (1H), 7.04 (1H), 7.38 (1H), 7.42 (1H), 8.38 (1H), 11.54 (1H). [0814] The starting material for the above title compound is prepared as follows: 23a) 2-Fluoro-5-bromophenylhydrazine hydrochloride [0815] [0816] A solution of 2.8 g of sodium nitrite in 14 ml of water is added dropwise over the course of 30 minutes to a solution of 7.59 g of 2-fluoro-5-bromoaniline in 25 ml of hydrochloric acid (37% strength) at 0° C. Then, at 0° C., a solution of 24.6 g of tin chloride in 21 ml of hydrochloric acid (37% strength) is added dropwise, and the mixture is stirred at this temperature for a further 1.5 hours. Addition of 60 ml of sodium hydroxide solution (50% strength) and 60 ml of ice-water (pH >10) is followed by dilution with 150 ml of water and extraction three times with 100 ml of ether each time. The combined organic phases are washed with half-saturated sodium chloride solution, dried over sodium sulfate. The filtrate is acidified with 20 ml of 4.0M HCl in 1,4-dioxane solution, and the resulting precipitate is then filtered off and dried. 8.28 g of the title compound are obtained in this way. [0817] NMR (300 MHz, DMSO-d6): δ=7.10-7.18 (1H), 7.21 (1H), 7.40 (1H), 8.59 (1H), 10.44 (3H). 23b) 2-(4-Bromo-7-fluoro-2-methyl-1H-indol-3-yl)ethylamine [0818] [0819] 3.7 g of the title compound are obtained in analogy to Example 17a from 8.0 g of hydrazine hydrochloride prepared in Example 23a) and 3.8 ml of 5-chloro-2-pentanone. [0820] NMR (300 MHz, DMSO-d6): δ=2.31 (3H), 2.67 (2H), 2.85 (2H), 6.71 (1H), 7.00 (1H), 11.55 (1H). EXAMPLE 24 N-[2-(4-Chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide [0821] [0822] 88 mg of the title compound are obtained in analogy to Example 1 from 100 mg of 2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethylamine and 133 mg of 3,4-dimethoxybenzoyl chloride. [0823] NMR (300 MHz, DMSO-d6): δ=2.26 (3H), 3.04 (2H), 3.41 (2H), 3.75 (3H), 3.76 (3H), 6.78 (1H), 6.87 (1H), 6.96 (1H), 7.38 (1H), 7.42 (1H), 8.39 (1H), 11.54 (1H). [0824] The starting material for the above title compound is prepared as follows: 24a) 2-Fluoro-5-chlorophenylhydrazine hydrochloride [0825] [0826] 12.2 g of the title compound are obtained in analogy to Example 23a from 10 g of 2-fluoro-5-chloroaniline. [0827] NMR (300 MHz, DMSO-d6): δ=6.96 (1H), 7.21 (1H), 7.17-7.26 (2H), 8.57 (1H), 10.42 (3H). 24b) 2-(4-Chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethylamine [0828] [0829] 4.7 g of the title compound are obtained in analogy to Example 17a from 12.2 g of the hydrazine hydrochloride prepared in Example 24a) and 7.1 ml of 5-chloro-2-pentanone. [0830] NMR (300 MHz, DMSO-d6): δ=2.31 (3H), 2.70 (2H), 2.86 (2H), 6.76 (1H), 6.85 (1H), 11.53 (1H). EXAMPLE 25 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methanesulfonylbenzamide [0831] [0832] 88 mg of the title compound are obtained in analogy to Example 12 from 100 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 91 mg of 4-methanesulfonylbenzoic acid. [0833] NMR (300 MHz, DMSO-d6): δ=2.28 (3H), 2.59 (3H), 2.97 (2H), 3.24 (3H), 3.36 (2H), 6.53-6.67 (2H), 7.99 (2H), 8.04 (2H), 8.91 (1H), 11.14 (1H). EXAMPLE 26 1H-Benzotriazole-5-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide [0834] [0835] 25 mg of the title compound are obtained in analogy to Example 12 from 50 mg of 2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethylamine and 39 mg of 1H-benzotriazole-5-carboxylic acid. [0836] NMR (300 MHz, DMSO-d6): δ=2.24 (3H), 2.93 (2H), 3.44 (2H), 6.60 (1H), 6.72 (1H), 7.88 (2H), 7.91 (1H), 8.35 (1H), 8.71 (1H), 11.44 (1H). EXAMPLE 27 1H-Indole-2-carboxylic acid [2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide [0837] [0838] 37 mg of the title compound are obtained in analogy to Example 12 from 50 mg of 2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethylamine and 38 mg of 1H-indole-2-carboxylic acid. [0839] NMR (300 MHz, DMSO-d6): δ=2.24 (3H), 2.91 (2H), 3.43 (2H), 6.60 (1H), 6.72 (1H), 6.98 (1H), 7.01 (1H), 7.12 (1H), 7.37 (1H), 7.55 (1H), 8.51 (1H), 11.42 (1H), 11.49 (1H). EXAMPLE 28 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxybenzamide [0840] [0841] 750 mg of the title compound are obtained in analogy to Example 1 from 500 mg of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 413 mg of 3,4-dimethoxybenzoyl chloride. [0842] NMR (300 MHz, DMSO-d6): δ=2.28 (3H), 2.59 (3H), 2.93 (2H), 3.31 (2H), 3.76 (3H), 3.77 (3H), 6.52-6.67 (2H), 6.98 (1H), 7.40 (1H), 7.44 (1H), 8.49 (1H), 11.12 (1H). EXAMPLE 29 4′-Fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide [0843] [0844] 0.51 ml of a 1 molar sodium carbonate solution and 30.5 mg of tetrakistriphenylphosphinepalladium are added to a mixture of 100 mg of the bromide from Example 29a) and 54 mg of 4-fluorophenylboronic acid in 3 ml of a mixture of ethanol and toluene in the ratio 1:1. This suspension is heated in a microwave (CEM) at 120° C./100 W under nitrogen for 15 min. The reaction mixture is added to 50 ml of saturated sodium bicarbonate solution and extracted three times with 50 ml of ethyl acetate each time. The combined organic phases are washed once with 50 ml of saturated sodium chloride solution, dried over sodium sulfate and, after filtration, concentrated in vacuo. The crude product obtained in this way is purified by medium pressure chromatography on silica gel with hexane/0-100% ethyl acetate. 37.9 mg of the title compound are obtained in this way. [0845] NMR (300 MHz, DMSO-d6): δ=2.29 (3H), 2.60 (3H), 2.97 (2H), 3.35 (2H), 6.53-6.68 (2H), 7.28 (2H), 7.69-7.79 (4H), 7.91 (2H), 8.69 (1H), 11.13 (1H). [0846] The starting material for the above title compound is prepared as follows: 29a) 4-Bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide [0847] [0848] 975 mg of the title compound are obtained in analogy to Example 1 from 1.0 g of 2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylamine hydrochloride and 895 mg of 4-bromobenzoyl chloride. [0849] NMR (300 MHz, DMSO-d6): δ=2.27 (3H), 2.58 (3H), 2.94 (2H), 3.31 (2H), 6.52-6.67 (2H), 7.65 (2H), 7.76 (2H), 8.71 (1H), 11.12 (1H). EXAMPLE 30 N-[2-(7-Fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-N′-pyridin-3-yl-terephthalamide [0850] [0851] 46 mg of the title compound are obtained in analogy to Example 12 from 50 mg of 2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethylamine and 57 mg of N-pyridin-3-yl-terephthalamic acid. [0852] NMR (300 MHz, DMSO-d6): δ=2.34 (3H), 2.65 (3H), 3.02 (2H), 3.42 (2H), 6.58-6.72 (2H), 6.88 (1H), 7.42 (1H), 8.01 (2H), 8.07 (2H), 8.21 (1H), 8.34 (1H), 8.87 (1H), 8.95 (1H), 10.57 (1H). [0853] Required starting materials for compounds in the table which follows: A) 2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethylamine [0854] [0855] A1) In analogy to example 17a), 7.07 g of 2-fluoro-5-trifluoromethylphenylamine affords 9.1 g of (2-fluoro-5-trifluoromethylphenyl)hydrazine hydrochloride. [0856] A2) In analogy to example 23a), 1 g of the hydrazine prepared above, by heating in a microwave at 120° C. for one hour, affords 460 mg of 2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethylamine. [0857] NMR (300 MHz, DMSO-d6): δ=2.46 (3H), 2.80 (2H), 3.03 (2H), 7.01 (1H), 7.38 (1H), 8.09 (2H), 12.14 (1H). B) 2-(7-fluoro-2-trifluoromethyl-4-methyl-1H-indol-3-yl)ethylamine [0858] B1) N-(2-fluoro-5-methylphenyl)-2-[(E)-hydroxyimino]acetamide [0859] [0860] To a solution at 100° C. of 36.4 g of chloral hydrate and 230 g of sodium sulfate in 780 ml of water is added a solution of 25 g of 2-fluoro-4-methyl-aniline, 17 ml of concentrated hydrochloric acid in 120 ml of water and a hot solution of hydroxylamine hydrochloride in 100 ml of water. This mixture is left to stand at 25° C. for 5 hours and then the precipitate formed is filtered off. The solid is washed with cold water and dried under air. In this way, 38 g of N-(2-fluoro-5-methylphenyl)-2-[(E)-hydroxyimino]acetamide are obtained as a slightly brownish solid. [0861] NMR (300 MHz, DMSO-d6): δ=2.25 (3H), 7.00 (1H), 7.05 (1H), 7.67 (2H), 9.67 (1H). B2) 7-fluoro-4-methyl-1H-indole-2,3-dione [0862] [0863] To a mixture of 386 g of 98% sulfuric acid and 43 ml of water are slowly added 36 g of the compound prepared above. During the addition, the temperature of the reaction mixture is kept between 75 and 80° C. and, after the addition, it is stirred at 80° C. for 15 minutes. Subsequently, the reaction mixture is added to 2 liters of ice-water and the precipitate formed is filtered off. The solid is washed with cold water and dried under air. In this way, 28.2 g of the title compound are obtained as a dark red solid. [0864] NMR (300 MHz, DMSO-d6): δ=2.48 (3H), 6.82 (1H), 7.35 (1H), 11.43 (1H). B3) (2-amino-3-fluoro-6-methylphenyl)methanol [0865] [0866] To a solution of 37.4 g of sodium hydroxide in 800 ml of water are added 27 g of the compound prepared above. To this mixture is added dropwise an aqueous H 2 O 2 solution (prepared from 41.6 ml of 30% H 2 O 2 solution and 360 ml of water), and the temperature is maintained between 25 and 30° C. during the dropwise addition. Subsequently, the mixture is stirred at 25° C. for 16 hours, acidified to pH approx. 5 with 36% hydrochloric acid and then concentrated under reduced pressure. The crude product thus obtained (2-amino-3-fluoro-6-methylbenzoic acid) is used further without additional purification. To a solution of 10 g of lithium aluminum hydride in 1 liter of tetrahydrofuran is slowly added, in portions of approx. 2 g, the acid prepared above at 10 to 15° C. After the complete addition, the reaction mixture is heated at reflux for 2 hours. After cooling, 10 ml of cold water are very cautiously added dropwise, followed by a solution of 3.3 g of sodium hydroxide in 10 ml of water. The mixture is heated at reflux and, after cooling, the precipitate formed is filtered off. The filtrate is concentrated under reduced pressure and the residue thus obtained is purified by column chromatography on silica gel with an eluent mixture of chloroform/methanol=19:1. In this way, 9 g of the title compound are obtained as a white solid. [0867] NMR (300 MHz, DMSO-d6): δ=2.20 (3H), 4.45 (2H), 4.86 (3H), 6.46 (1H), 6.82 (1H). B4) N-(6-fluoro-2-hydroxymethyl-3-methylphenyl)trifluoroacetamide [0868] [0869] To a solution of 1.0 g of the aniline prepared above in 30 ml of methylene chloride are added dropwise 2.68 g of trifluoroacetic anhydride at 0° C. with stirring. On completion of addition, the mixture is allowed to warm up to 25° C. and is stirred at this temperature for 16 hours. The organic phase is then washed with 15% potassium carbonate solution, dried over sodium sulfate and, after filtration, concentrated under reduced pressure. The residue thus obtained is extracted with hot hexane and then the hexane phases are concentrated cautiously under reduced pressure. The trifluoroacetamide thus obtained is used in the next stage without further purification. [0870] NMR (300 MHz, DMSO-d6): δ=2.33 (3H), 5.41 (2H), 7.37 (2H), 11.25 (1H). B5) 7-fluoro-4-methyl-2-trifluoromethyl-1H-indole [0871] [0872] A mixture of 1 g of the compound prepared above and 1.51 g of triphenylphosphine hydrobromide in 50 ml of acetonitrile is heated under reflux for 17 hours. Subsequently, this mixture is concentrated under reduced pressure and washed with 50 ml of diethyl ether, and the residue is dried under air. In this way, 1.88 g of (2-trifluoroacetylamino-3-fluoro-6-methylbenzyl)triphenylphosphonium bromide are obtained as a yellow solid which is used in the next stage without further purification. [0873] A solution of 18.9 g of the phosphonium salt prepared above in 600 ml of DMF is heated under reflux for 20 hours. After cooling, the mixture is concentrated under reduced pressure and the residue thus obtained is purified by means of column chromatography on silica gel with hexane. In this way, 4.3 g of the title compound are obtained as a pale yellow oil. [0874] NMR (300 MHz, DMSO-d6): δ=2.45 (3H), 6.84 (1H), 6.98 (1H), 7.20 (1H), 12.72 (1H). B6) (7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-ylmethyl)dimethylamine [0875] [0876] To a solution of 0.47 g of potassium carbonate in 7.5 ml of acetic acid are added, at −10° C., 0.56 g of dimethylamine hydrochloride in 7.5 ml of dioxane, followed by 0.42 ml of 40% formaldehyde solution and 1 g of the indole prepared above in 7.5 ml of dioxane. Subsequently, this mixture is stirred at 25° C. for 2 hours and then heated to 80° C. for a further 5 hours. After cooling, the reaction mixture is then concentrated under reduced pressure and added to 15% potassium carbonate solution. After extraction three times with 30 ml each time of ethyl acetate, the combined organic phases are dried over sodium sulfate. After filtration, the mixture is concentrated under reduced pressure and the residue thus obtained is purified by means of column chromatography on silica gel with 19:1 hexane/ethyl acetate. In this way, 0.5 g of the title compound is obtained as a white solid. [0877] NMR (300 MHz, DMSO-d6): δ=2.18 (6H), 2.71 (3H), 3.58 (2H), 6.78 (1H), 6.98 (1H), 7.20 (1H), 12.41 (1H). B7) (7-fluoro-4-methyl-2-trifluoromethyl-1H-indol-3-yl)acetonitrile [0878] [0879] To a solution of 0.51 g of the amine prepared above in 10 ml of DMF is added a solution of 1.24 g of potassium cyanide in 100 ml of water, and this mixture is heated under reflux for 2 hours. After cooling, the mixture is concentrated under reduced pressure and the residue thus obtained is purified by column chromatography on silica gel with 9:1 hexane/ethyl acetate. In this way, 0.22 g of the title compound is obtained as a white solid. [0880] NMR (300 MHz, DMSO-d6): δ=2.72 (3H), 4.30 (2H), 6.89 (1H), 7.07 (1H), 12.90 (1H). B8) 2-(7-fluoro-2-trifluoromethyl-4-methyl-1H-indol-3-yl)ethylamine [0881] [0882] To a solution of 1.8 g of the nitrile prepared above in 40 ml of ethanol are added, with stirring at 25° C., a solution of 3.49 g of cobalt diacetate tetrahydrate in 40 ml of ethanol, followed by 2.65 g of sodium borohydride, and then the mixture is stirred at this temperature for 17 hours. The mixture is then concentrated under reduced pressure and the residue thus obtained is purified by column chromatography on silica gel with chloroform/methanol/aq. NH 3 in a ratio of 100:10:1. In this way, 1.37 g of the title compound are obtained as a gray-yellow solid. [0883] NMR (300 MHz, DMSO-d6): δ=2.63 (3H), 2.77 (2H), 3.00 (2H), 4.98 (2H), 6.76 (1H), 6.95 (1H), 12.90 (1H). [0884] The following examples are prepared in analogy to Example 1 or 29 and purified by HPLC: [0885] HPLC-method: [0886] Instrument: analytical 4-channel MUX system with CTC Pal injector, Waters 1525 pumps, Waters 2488 UV detector and Waters ZQ 2000 single quad MS detector. [0887] Column X-Bridge RP C18 4.6×50 3.5 μm; detection wavelength 214 nm; flow rate 2 ml/min; eluents A: 0.1% TFA in H2O, B 0.1% TFA in ACN; gradient based in each case on B: 1% to 99% (5′) to 99% (1′) to 1% (0.25°) to 1% (1.75°) [0000] or in the case of the retention times below 2 minutes: detection: UV=200-400 nm (Waters Acquity HPLC)/MS 100-800 Daltons; 20 V (Micromass/Waters ZQ 4000); column: X Bridge (Waters), 2.1×50 mm, BEH 1.7 μm; eluents: A: H2O/0.05% HCOOH, B: CH3CN/0.05% HCOOH. Gradient: 10-90% B in 1.7 min, 90% B for 0.2 min, 98-2% B in 0.6 min; flow rate: 1.3 ml/min. [0000] Theoret- ical Mass Reten- Ex- mass found tion am- m/z m/z time ple Structure Name [M + H] + [M + H] + [min.] 31 4-amino-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 326 327 6.84 32 5-bromofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 379 380 9.29 33 N-[2-(7-fluoro-2,4dimethyl-1H-indol-3-yl)ethyl]-isonicotinamide 312 313 6.25 34 N-[2-(7-fluoro-2,4dimethyl-1H-indol-3-yl)ethyl]benzamide 311 312 9.04 35 2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)-ethyl]benzamide 329 330 9.3 36 3-fluoro-N-]2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 329 330 9.27 37 1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 350 351 9.42 38 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-methyl-nicotinamide 326 327 6.25 39 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methoxy-benazmide 341 342 9.15 40 4-ethoxy-N-[2-(7-fluoro-2,4-dimethyl- 1H-indol-3-yl)ethyl]benzamide 355 356 9.5 41 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxy-3,5-dimethoxy-benzamide 387 388 7.94 42 1H-benzotriazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 352 353 7.45 43 5-methylthiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 331 332 9.37 44 1H-pyrrole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 300 301 8.25 45 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylamino-benzamide 340 341 8.24 46 thiophene-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 317 318 8.84 47 6-cyano-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-nicotinamide 337 338 8.65 48 1H-benzoimidazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 351 352 6.28 49 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-trifluoro-methylbenzamide 379 380 9.94 50 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxy-3-methoxy-benzamide 357 358 8.02 51 4-dimethylamino-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 354 355 7.89 52 4-cyano-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 336 337 9.02 53 isoxazole-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 302 303 8.17 54 4-acetyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-benzamide 353 354 8.75 55 4-chloro-3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 363 364 10.12 56 4-chloromethyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 359 360 9.37 57 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,5-dimethylbenzamide 339 340 9.88 58 3,4-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-benzamide 347 348 9.63 59 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-propylbenzamide 353 354 10.44 60 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-hydroxy-4-methylbenzamide 341 342 8.4 61 2,3-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 347 348 9.49 62 3,5-difluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 347 348 9.77 63 naphthalene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 361 362 9.92 64 5-chlorothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 351 352 10.05 65 6-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-nicotinamide 330 331 8.59 66 3-chloromethyl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 359 360 9.55 67 4-butoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 383 384 10.55 68 4-acetoxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 369 370 8.85 69 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-methylsulfanyl-benzamide 357 358 9.55 70 4-cyano-2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 354 355 9.2 71 isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 362 363 9.79 72 isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 350 351 8.44 73 isoquinoline-1-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 364 365 10.25 74 3,5-dichloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 379 380 10.85 75 quinoline-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361 362 8.38 76 quinoline-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 343 344 7.08 77 4-hydroxy-2-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 392 393 8.61 78 benzo[b]thiophene-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl[amide 366 367 10.38 79 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-hydroxybenzamide 326 327 8.45 80 pyrazine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 312 313 8.67 81 furan-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 300 301 8.85 82 quinoline-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361 362 8.97 83 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yI)ethyl]-nicotinamide 346 347 8.58 84 4-benzyloxy-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 416 417 10.8 85 5-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-nicotinamide 390 391 9.44 86 1H-indole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 349 350 8.98 87 3-bromothiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 395 396 10.25 88 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 405 406 9.47 89 2-methylfuran-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 314 315 9.35 90 1H-imidazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 300 301 6.35 91 4-oxo-4,5,6,7-tetrahydro-benzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 384 385 9.42 92 4′-bromobiphenyl-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 465 466 10.83 93 2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-iodobenzamide 454 455 9.82 94 2,3-dihydro-benzofuran-7-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 352 353 9.86 95 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 342 343 9.8 96 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2,5-dimethylbenzamide 338 339 10.02 97 5-acetylthiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 358 359 9.21 98 quinoline-8-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361 362 9.92 99 2-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 376 377 9.4 100 6-phenylpyrimidine-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 388 389 10.98 101 1-methyl-1H-indole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 363 364 11.32 102 2-pyridin-3-ylthiazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 394 395 9.17 103 2,5-dimethyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 328 329 8.83 104 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-phenoxymethyl-benzamide 416 417 10.67 105 2,3-dihydro-benzofuran-5-carboxylic acid [2-(7-1H-indol-3-yl)ethyl]amide 352 353 9.33 106 1H-indole-6-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 349 350 9.17 107 2-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4,5-dimethoxy-benzamide 449 450 9.38 108 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-pyrrolidin-1-ylbenzamide 379 380 10.31 109 quinoline-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361 362 6.88 110 5-phenyl-1H-pyrazole-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 376 377 8.53 111 pyridazine-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 312 313 7.57 112 5-phenyl-2H-pyrazole-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 376 377 9.38 113 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-pyrrol-1-yl-nicotinamide 376 377 9.27 114 pyrimidine-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 312 313 7.85 115 benzo[b]thiophene-5-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 366 367 10.11 116 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-piperidin-1-ylbenzamide 394 395 7.25 117 pyrazolo[1,5-a]pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 350 351 9.33 118 quinoxaline-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 362 363 10.13 119 3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methoxy-benzamide 358 359 10.07 120 3-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-methylbenzamide 359 360 10.23 121 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-phenoxbenzamide 402 403 10.75 122 thiazole-4-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 317 318 8.88 123 2-chloro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-3-methylbenzamide 359 360 9.93 124 3-chloro-2-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 363 364 10.22 125 5-methoxy-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 379 380 9.36 126 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 367 368 9.55 127 5-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 363 364 9.84 128 4-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 363 364 9.83 129 6-methoxy-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 379 380 9.41 130 4-methoxy-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 379 380 9.41 131 4-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 367 368 9.85 132 7-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 363 364 10.67 133 6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 367 368 9.66 134 6-methyl-1H-indole-2-carboxylic acid [2-7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 363 364 9.92 135 5-methoxy-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 351 352 8.73 136 1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 321 322 8.87 137 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 339 340 8.95 138 5-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 335 336 9.2 139 6-methoxy-1H-indole-2-carboxylicacid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 351 352 8.74 140 4-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 335 336 9.18 141 4-dimethylamino-N-[2-(7-fluoro-1H-indol-3-yl)ethyl]benzamide 325 326 7.63 142 N-[2-(7-fluoro-1H-indol-3-yl)ethyl]-4-pyrrolidin-1-ylbenzamide 351 352 9.22 143 1H-indole-6-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 321 322 8.21 144 4-methoxy-1H-indole-2-carboxylicacid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 351 352 8.88 145 4-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 339 340 9.02 146 6-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 339 340 9.03 147 6-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 335 336 9.28 148 7-methyl-1H-indole-2-carboxylic acid [2-(7-fluoro-1H-indol-3-yl)ethyl]amide 335 336 9.22 149 5-bromo-2,3-dihydrobenzofuran-7-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 432 433 8.04 150 4-(1H-benzoimidazol-2-yl)-N-[2-(7-fluoro-1H-indol-3-yl)ethyl]benzamide 398 399 6.51 151 4-(1H-benzoimidazol-2-yl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 426 427 6.95 152 [1,1′;4′,1″]terphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 462.5653 464 4.99 153 3′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 400.4945 401 4.69 154 3′-fluoro-4′-methyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 418.4846 419 4.72 155 2′-fluoro-4′-methyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 418.4846 419 4.72 156 4′-hydroxymethyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 416.4935 417 3.81 157 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-4-carboxylic acid 430.4767 431 3.86 158 4′-tert-butylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 442.5749 444 5.12 159 4′-chlorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 420.9128 422 4.72 160 3′,4′,5′-trimethoxy-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 476.5451 478 4.19 161 3′-trifluoromethoxy-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 470.4638 471 4.84 162 4′-trifluoromethoxy-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 470.4638 471 4.8 163 3′-hydroxybiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 402.4667 403 3.97 164 4′-methanesulfinyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl amide 448.5595 450 3.64 165 3′-cyanomethyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 425.5046 427 4.17 166 2′-acetylamino-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 443.5194 445 3.72 167 3′-fluoro-4′-methoxy-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 434.4836 435 4.36 168 3′-chloro-4′-fluoro-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 438.9029 440 4.74 169 3′,4′-difluoro-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 422.4479 423 4.55 170 3′,5′-difluoro-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 422.4479 423 4.57 171 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(5-hydroxymethyl-thiophen-2-yl)-benzamide 422.5217 424 3.82 172 3′-methanesulfonyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 464.5585 466 3.94 173 4-fluoro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-3-carboxylic acid 448.4668 449 3.89 174 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-3-methoxybiphenyl-4-carboxylic acidmethyl ester 474.5293 476 4.2 175 5-fluoro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-3-carboxylic acid 448.4668 449 4 176 3-chlorobiphenyl-4,4′-dicarboxylic acid4-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 463.9377 465 3.69 177 3-chlorobiphenyl-4,4′-dicarboxylic acid4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 4-methylamide 477.9645 479 3.81 178 3′-dimethyl-sulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 493.6002 495 4.2 179 biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 3-thiazol-2-ylamide 512.6065 514 4.15 180 4′-methylsulfamoyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 479.5734 481 3.9 181 4′-dimethyl-sulfamoylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 493.6002 495 4.21 182 biphenyl-3,4′-dicarboxylic acid 3-diethylamide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 485.5998 487 4.14 183 biphenyl-4,4′-dicarboxylic acid 4- diethylamide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 485.5998 487 4.1 184 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-biphenyl-3-carboxylic acid 430.4767 431 3.87 185 biphenyl-4,4′-dicarboxylic acid4-amide 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 429.4926 430 3.59 186 3′-methylsulfamoyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 479.5734 481 3.97 187 3′-trifluoromethyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 454.4648 455 4.73 188 4-methylsulfanyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 432.5605 434 4.62 189 4′-acetylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 428.5045 430 4.21 190 3′-aminobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 401.4826 402 3.27 191 3′-acetylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 428.5045 430 4.22 192 3′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 404.4578 405 4.51 193 [1,1′;3′,1″]terphenyl-4-carboxylic acid [2-(7-fluoro-2,4-nl dimethyl-1H-indol-3-yl)ethyl]amide 462.5653 464 5.01 194 3′-hydroxymethyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 416.4935 417 3.87 195 4-benzo[b]thiophen-3-yl-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]benzamide 442.5557 444 4.79 196 4′-trifluoromethyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 454.4648 455 4.76 197 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-((E)-styryl)benzamide 412.5055 414 4.72 198 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-quinolin-6-ylbenzamide 437.5156 439 3.32 199 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(6-methoxypyridin-3-yl)-benzamide 417.4816 418 4.1 200 biphenyl-3,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 3-methylamide 443.5194 445 3.72 201 biphenyl-4,4′-dicarboxylic acid 4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 4-methylamide 443.5194 445 3.69 202 2′-fluorobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 404.4578 405 4.45 203 2′-methylbiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 400.4945 401 4.62 204 3′-acetylamino-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 443.5194 445 3.84 205 4-benzo[1,3]dioxol-5-yl-N-[2-(7-fluoro-2,4-dimethyl-1H-yl)ethyl]benzamide 430.4767 431 4.38 206 3′-cyanobiphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 411.4778 412 4.27 207 4′-cyanomethyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 425.5046 427 4.12 208 biphenyl-3,4′-dicarboxylic acid 3-amide 4]-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 429.4926 430 3.79 209 3′,5′-dimethyl-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 414.5213 416 4.89 210 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-quinolin-3-ylbenzamide 437.5156 439 3.52 211 4′-acetylamino-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 443.5194 445 3.75 212 3′-fluoro-5′-methoxy-biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 434.4836 435 4.62 213 5-fluorobiphenyl-3,4′-dicarboxylic acid4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide} 3-methylamide 461.5095 463 3.88 214 3′-(acetylamino-methyl)biphenyl-4-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 457.5462 459 3.71 215 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(1-methyl-1H-indol-5-yl)-benzamide 439.5314 441 4.47 216 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-(1-methyl-1H-indol-2-yl)-benzamide 439.5314 441 4.69 217 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-pyrrol-1-yl-nicotinamide 376 377 9.27 218 N-[2-(4-cyano-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 381 382 1.10 219 5-benzyloxy-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 455 456 1.44 220 5-hydroxy-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 365 366 1.10 221 5-methoxybenzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 380 381 1.35 222 6-hydroxy-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 365 366 1.14 223 N-[2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 424 425 1.22 224 3H-benzotriazole-5-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 405 406 1.13 225 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 421 422 1.35 226 quinoxaline-6-carboxylic acid [2-(7-fluoro-2-methyl-4-trifluoromethyl-1H-indol-3-yl)ethyl]amide 416 415 1.20 227 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}acetic acidmethyl ester 437 438 1.27 228 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}butanoicacid ethyl ester 479 480 1.38 229 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}pentanoicacid ethyl ester 493 494 1.43 230 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}hexanoicacid ethyl ester 507 508 1.49 231 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}acetic acidmethyl ester 437 438 1.28 232 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}butanoicacid ethyl ester 479 480 1.41 233 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}pentanoicacid ethyl ester 493 494 1.45 234 {2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}hexanoicacid ethyl ester 507 508 1.50 235 6-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 389 390 1.45 236 5-fluoro-1H-indole-2-carboxylic acid [2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 353 354 1.20 237 4-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 389 390 1.31 238 6-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]nicotinamide 389 390 1.20 239 {3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]phenoxy}acetic acidmethyl ester 398 399 1.20 240 4-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoicacid ethyl ester 440 441 1.36 241 5-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoicacid ethyl ester 454 455 1.43 242 2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}acetic acid 423 424 1.10 243 4-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}butanoicacid 451 452 1.16 244 5-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}pentanoicacid 465 466 1.22 245 6-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoicacid ethyl ester 468 469 1.48 246 5-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}pentanoicacid 465 466 1.20 247 6-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-5-yloxy}hexanoicacid 479 480 1.26 248 4-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}-butanoic acid 451 452 1.22 249 6-{2-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}hexanoicacid 479 480 1.29 250 4-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoicacid 412 413 1.17 251 {2-[2-(7-fluoro-2,4-dimethyl-1 H-indol-3-yl)ethylcarbamoyl]-1H-indol-6-yloxy}acetic acid 423 424 1.12 252 4-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoicacid ethyl ester 440 441 1.28 253 5-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoicacid ethyl ester 454 455 1.29 254 6-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoicacid ethyl ester 468 469 1.36 255 6-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoicacid 440 441 1.15 256 4-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}butanoicacid 412 413 1.04 257 5-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoicacid 426 427 1.12 258 6-{4-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}hexanoicacid 440 441 1.13 259 5-{3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethylcarbamoyl]-phenoxy}pentanoicacid 426 427 1.21 260 2-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]isonicotin-amide 390 390 1.26 261 {4-[2-(7-fluoro-2,4-dimethyl-1H-indol-yl)ethylcarbamoyl]phenoxy}acetic acid 384 385 0.90 262 5-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 427 426[M − H] 1.30 263 6-bromo-1H-indole-2-carboxylic acid [2-(7-fluoro-2,4-diimethyl-1H-indol-3-yl)ethyl]amide 427 426[M − H] 1.30 264 5-bromopyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 464 465 1.26 265 6-(3-carbamoyl-phenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)-ethyl]amide 430 431 1.16 266 6-(3-methyl-carbamoylphenyl)-pyridine-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 444 445 1.23 267 6-(3-hydroxy-phenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)-ethyl]amide 403 404 1.27 268 4-(3-carbamoyl-phenyl)pyridine-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)-ethyl]amide 430 431 1.19 269 4-(3-methyl-carbamoylphenyl)-pyridine-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 444 445 1.23 270 4-(3-hydroxyphenyl)-pyridine-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 403 404 1.30 271 4-(4-methyl-carbamoylphenyl)-pyridine-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 444 445 1.23 272 5-chloro-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 383 384 1.39 273 benzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 350 351 1.39 274 5-chlorobenzofuran-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 384 385 1.48 275 4-bromo-3-fluoro-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-benzamide 406 407 1.39 276 4-chloro-4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl-carbamoyl]biphenyl-3-carboxylic acid 464 465 1.27 277 {3-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl-carbamoyl]-phenoxy}acetic acid 384 383 1.09 278 5-(3-carbamoyl-phenyl)pyridine-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 430 431 1.17 279 5-(3-methyl-carbamoylphenyl)-pyridine-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 444 445 1.21 280 5-(3-hydroxyphenyl)-pyridine-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 403 404 1.27 281 6-(3-carbamoyl-phenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-nicotinamide 430 431 1.10 282 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(3-methylcarbamoyl-phenyl)nicotinamide 444 445 1.13 283 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(3-hydroxyphenyl)-nicotinamide 403 404 1.17 284 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-6-(4-methylcarbamoyl-phenyl)nicotinamide 444 445 1.12 285 5-(3-carbamoyl-phenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yI)ethyl]-nicotinamide 430 431 1.05 286 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(3-methylcarbamoyl-phenyl)nicotinamide 444 445 1.10 287 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(3-hydroxyphenyl)-nicotinamide 403 404 1.14 288 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-5-(4-methylcarbamoyl-phenyl)nicotinamide 444 445 1.07 289 2-(3-carbamoyl-phenyl)-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-isonicotinamide 430 431 1.10 290 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-(3-methylcarbamoylphenyl)isonicotin-amide 444 445 1.14 291 N-[2-(7-fluoro-2 4-dimethyl-1H-indol-3-yl)ethyl]-2-(3-hydroxyphenyl)-isonicotinamide 403 404 1.17 292 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-2-(4-methylcarbamoylphenyl)isonicotin-amide 444 445 1.12 293 benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 366 365 1.37 294 quinoline-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361 362 1.47 295 [1,8]naphthyridine-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 362 363 1.23 296 isoquinoline-3-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 361 362 1.37 297 5-pyridin-2-yl-thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 393 394 1.35 298 5-trifluoromethoxy-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 433 432 1.33 299 5-fluoro-1H-indole-2-carboxylic acid[2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 371 372 1.32 300 biphenyl-3,4′-dicarboxylic acid4′-{[2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 447 448 1.22 301 6-(3-trifluoro-methoxyphenyl)-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 509 511 0.97 302 5-(4-methyl-carbamoylphenyl)-pyridine-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 444 445 1.21 303 4′-methoxybiphenyl-4-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 416 417 4.42 304 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl-carbamoyl]-3-methoxybiphenyl-4-carboxylic acid 460 462 3.84 305 4′-methoxybiphenyl-3-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H- indol-3-yl)ethyl]-amide 416 417 4.44 307 4-(4-methyl-carbamoylphenyl)-thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 449 450 1.22 308 4-(3-methyl-carbamoylphenyl)-thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 449 450 1.25 309 4-(3-methyl-carbamoylphenyl)-thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 449 450 1.25 310 4-(3-hydroxyphenyl)-thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 408 409 1.30 311 4-(3-carbamoyl-phenyl)thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 435 436 1.18 312 4-bromothiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 395 395 1.35 313 2-fluorobiphenyl-4,4′-dicarboxylic acid4-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide} 4′-methyl-amide 461 462 1.25 314 2′-fluorobiphenyl-3,4′-dicarboxylic acid3-amide4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide} 447 448 1.21 315 2-fluoro-3′-hydroxy-biphenyl-4-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 420 421 1.32 316 2′-fluorobiphenyl-3,4′-dicarboxylic acid4′-{[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide} 3-methyl-amide 461 462 1.25 317 5-(3-methyl-carbamoylphenyl)1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 482 483 1.25 318 5-bromothiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 394 395 1.38 319 3′-hydroxybiphenyl-4-carboxylic acid[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 388 389 1.22 320 biphenyl-4,4′-dicarboxylic acid4′-{[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}4-methylamide 429 430 1.14 321 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl-carbamoyl]-3-hydroxybiphenyl-4-carboxylic acidmethyl ester 460 459 1.44 322 N-[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-6-(3-methyl-carbamoylphenyl)-nicotinamide 430 431 1.09 323 biphenyl-3,4′-dicarboxylic acid4′-{[2-(8-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide}3-methylamide 429 430 1.16 324 5-(3-carbamoyl-phenyl)-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 468 469 1.22 325 5-(3-hydroxyphenyl)-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 441 442 1.31 326 5-(4-methyl-carbamoylphenyl)-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 482 483 1.24 327 5-(3-methyl-carbamoylphenyl)-thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 449 450 1.25 328 5-(3-carbamoyl-phenyl)thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 435 436 1.21 329 5-(3-hydroxy-phenyl)thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 408 409 1.28 330 5-(4-methyl-carbamoylphenyl)-thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 449 450 1.21 331 6-(3-methyl-carbamoylphenyl)-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 482 483 1.28 332 6-(3-carbamoyl-phenyl)-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 468 469 1.23 333 6-(3-hydroxyphenyl)-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 441 442 1.32 334 6-(4-methyl-carbamoylphenyl)-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 482 483 1.26 335 3′-cyano-2′-fluorobiphenyl-4-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 429 430 1.38 336 5-chloro-1H-indole-2-carboxylic acid[2-(7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 369 370 1.35 337 5-chloro-1H-indole-2-carboxylic acid[2-(4,7-difluoro-2-methyl-1H-indol-3-yl)ethyl]amide 387 388 1.37 338 5-chloro-1H-indole-2-carboxylic acid[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 404 404 1.44 339 5-trifluoromethyl-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 417 416[M − H] 1.44 340 6-methanesulfonyl-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 427 428 1.19 341 7-chloro-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 383 382 1.39 342 4-chloro-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 383 382[M − H] 1.40 343 6-chloro-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 383 382 1.39 344 7-fluoro-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 367 368 1.33 345 5-bromo-1H-indole-2-carboxylic acid[2-(7-fluoro-4-methyl-2-trifluoro-methyl-1H-indol-3-yl)ethyl]amide 483 484 1.46 346 5-trifluoromethyl-1H-indole-2-carboxylicacid [2-(7-fluoro-4-methyl-2-trifluoro-methyl-1H-indol-3-yl)ethyl]amide 471 472 1.48 347 5-chloro-1H-indole-2-carboxylic acid[2-(7-fluoro-4-methyl-2-trifluoro-methyl-1H-indol-3-yl)ethyl]amide 437 438 1.44 348 5-trifluoromethoxy-1H-indole-2-carboxylic acid[2-(7-fluoro-4-methyl-2-trifluoro-methyl-1H-indol-3-yl)ethyl]amide 487 488 1.49 349 N-[2-(7-fluoro-4-methyl-2-trifluoro-methyl-1H-indol-3-yl)ethyl]-3,4-dimethoxy-benzamide 424 425 1.26 350 biphenyl-3,4′-dicarboxylic acid4′-{[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]-amide} 3-methyl-amide 463 464 1.25 351 5-fluoro-1H-indole-2-carboxylic acid[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 387 388 1.36 352 5-trifluoromethoxy-1H-indole-2-carboxylic acid[2-(4-chloro-7-fluoro-2-methyl-1H-indol-3-yl)ethyl]amide 453 454 1.48 353 4′-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl-carbamoyl]-3-hydroxybiphenyl-4-carboxylic acid 446 447 1.29 354 4-bromo-N-[2-(4-fluoro-2,7-dimethyl-1H-indol-3-yl)ethyl]-benzamide 389 389 1.33 355 4,5,6,7-tetrahydro-benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 370 371 1.43 356 N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-4-hydroxy-benzamide 326 327 1.10 357 3-bromo-N-[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-benzamide 390 391 1.36 358 6-isopropoxy-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 407 408 1.40 359 5-isopropyl-1H-indol-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 391 392 1.49 360 6-trifluoromethyl-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 417 418 1.44 361 4,5,6,7-tetrahydro-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 353 354 1.34 362 5-methanesulfonyl-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 427 428 1.18 363 3-methyl-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 363 364 1.38 364 5-fluoro-benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 384 385 1.44 365 5-trifluoromethyl-benzo[b]thiophene-2-carboxylic acid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]amide 434 433[M − H] 1.52 366 5-trifluoromethoxy-benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 450 449[M − H] 1.53 367 6-trifluoromethoxy-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 433 434 1.46 368 6-tert-butyl-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 405 406 1.53 369 benzothiazole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 367 368 1.44 370 benzoxazole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 351 352 1.31 371 3′-(2,5-dioxo-imidazolidin-4-yl)-biphenyl-4-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 484 485 1.16 372 6-amino-1H-indole-2-carboxylic acid2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 364 365 0.94 373 5-dimethyl-carbamoylmethoxy-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 450 451 1.16 374 6-dimethyl-carbamoylmethoxy-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 450 451 1.19 375 6-acetylamino-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 406 407 1.14 376 6-(2,2-dimethyl-propionylamino)-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 448 449 1.30 377 5-(2,2-dimethyl-propionylamino)-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 448 449 1.28 378 5-acetylamino-1H-indole-2-carboxylicacid [2-(7-fluoro-2,4-dimethyl-1H-amide 406 407 1.10 379 5-bromo-benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 446 447 1.51 380 6-bromo-benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 446 447 1.51 381 6-trifluoromethyl-benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 434 433 1.52 382 6-chloro-benzo[b]thiophene-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 400 399[M − H] 1.50 383 6-methylcarbamoyl-methoxy-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 436 437 1.17 384 5-methylcarbamoyl-methoxy-1H-indole-2-carboxylic acid[2-(7-fluoro-2,4-dimethyl-1H-indol-3-yl)ethyl]-amide 436 437 1.15 BIOLOGICAL EXAMPLES 1. Detection of the Antagonism of the Human Prostaglandin E 2 (Subtype EP 2 Receptor Signal 1.1 Principle of Detection [0888] The binding of PGE 2 to the EP 2 subtype of the human PGE 2 receptor induces activation of membrane-associated adenylate cyclases and leads to the formation of cAMP. In the presence of the phosphodiesterase inhibitor IBMX, cAMP which has accumulated due to this stimulation and been released by cell lysis is employed in a competitive detection method. In this assay, the cAMP in the lysate competes with cAMP-XL665 for binding of an Eu cryptate-labelled anti-cAMP antibody. [0889] This results, in the absence of cellular cAMP, in a maximum signal which derives from coupling of this antibody to the cAMP-XL665 molecule. After excitation at 337 nm, this results in a FRET (fluorescence resonance energy transfer)-based, long-lived emission signal at 665 nm (and at 620 nM). The two signals are measured in a suitable measuring instrument with a time lag, i.e. after the background fluorescence has declined. Any increase in the low FRET signal caused by prostaglandin E 2 addition (measured as well ratio change=emission 665 nm /emission 620 nm *10 000) shows the effect of antagonists. 1.2. Detection Method 1.2.1 Antagonism Assay (Data for Each Well of a 384-Well Plate): [0890] The substance solutions (0.75 μl) introduced into an assay plate and 30% DMSO are dissolved in 16 μl of a KRSB+IBMX stimulation solution (1× Krebs-Ringer Bicarbonate Buffer; Sigma-Aldrich # K-4002; including 750 μM 3-isobutyl-1-methylxanthine Sigma-Aldrich # I-7018), and then 15 μl thereof are transferred into a media-free cell culture plate which has been washed with KRSB shortly beforehand. [0891] After preincubation at room temperature (RT) for 30 minutes, 5 μl of a 4×PGE2 solution (11 nM) are added, and incubation is carried out in the presence of the agonist at RT for a further 60 min (volume: ˜20 μl) before the reaction is then stopped by adding 5 μl of lysis buffer and incubated at RT for a further 20 min (volume: 25 μl). The cell lysate is then transferred into a measuring plate and measured in accordance with the manufacturer's information (cyclic AMP kit Cisbio International # 62AMPPEC). 1.2.2 Agonism Assay (Data for Each Well of a 384-Well Plate): [0892] The substance solutions (0.75 μl) introduced into an assay plate and 30% DMSO are dissolved in 16 μl of a KRSB+IBMX stimulation solution (1× Krebs-Ringer Bicarbonate Buffer; Sigma-Aldrich # K-4002; including 750 μM 3-isobutyl-1-methylxanthine Sigma-Aldrich # I-7018), and then 15 μl thereof are transferred into a media-free cell culture plate which has been washed with KRSB shortly beforehand. [0893] After incubation at room temperature (RT; volume: ˜15 μl) for 60 minutes, the reaction is then stopped by adding 5 μl of lysis buffer and incubated at RT for a further 20 min (volume: ˜20 μl). The cell lysate is then transferred into a measuring plate and measured in accordance with the manufacturer's information (cyclic AMP kit Cisbio International # 62AMPPEC). 2. The EP 2 Subtype of the PGE 2 Receptor and the Preovulatory Cumulus Expansion 2.1. Background: [0894] In the preovulatory antral follicle, the oocyte is surrounded by cumulus cells which form a dense ring of cells around the oocyte. After the LH peak (lutenizing hormone), a series of processes is activated and leads to a large morphological change in this ring of cells composed of cumulus cells. In this case, the cumulus cells form an extracellular matrix which leads to so-called cumulus expansion (Vanderhyden et al. Dev Biol. 1990 August; 140(2):307-317). This cumulus expansion is an important component of the ovulatory process and of the subsequent possibility of fertilization. [0895] Prostaglandins, and here prostaglandin E 2 , whose synthesis is induced by the LH peak, are of crucial importance in cumulus expansion. Prostanoid EP 2 knockout mice (Hizaki et al. Proc Natl Acad Sci USA. 1999 Aug. 31; 96(18):10501-6.) show a markedly reduced cumulus expansion and severe subfertility, demonstrating the importance of the prostanoid EP 2 receptor for this process. 2.2 Cumulus Expansion Assay In Vitro [0896] Folliculogenesis is induced in immature female mice (strain: CD1 (ICR) from Charles River) at an age of 14-18 days by a single dose (intraperitoneal) of 10 I.U. of PMSG (Pregnant Mare Serum Gonadotropine; Sigma G-4877, Lot 68H0909). 47-50 hours after the injection, the ovaries are removed and the cumulus-oocyte complexes are removed. The cumulus complex is not yet expanded at this stage. [0897] The cumulus-oocyte complexes are then incubated with prostaglandin E2 (PGE2) (0.3 μM), vehicle control (ethanol) or test substances for 20-24 hours. Medium: alpha-MEM medium with 0.1 mM IBMX, pyruvates (0.23 mM) glutamines (2 mM), pen/strep 100 IU/ml pen. and 100 μg/ml strep.) and HSA (8 mg/ml)). Cumulus expansion is then established through the division into four stages (according to Vanderhyden et al. Dev Biol. 1990 August; 140(2):307-317). [0000] TABLE 1 Example of the biological activity of the compounds of the invention (measured by the cAMP antagonism assay): Substance of Example Antagonism [IC 50 , μM] 2 6.8 6 1.5 29 1.2 [0898] Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The preceding preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever. [0899] In the foregoing and in the examples, all temperatures are set forth uncorrected in degrees Celsius and, all parts and percentages are by weight, unless otherwise indicated. [0900] The entire disclosures of all applications, patents and publications, cited herein and of corresponding European application No. 07090121.0, filed Jun. 13, 2007 are incorporated by reference herein. [0901] The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples. [0902] From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention and, without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (4)

    Publication numberPublication dateAssigneeTitle
    US-2004254233-A1December 16, 2004Araldi Gian Luca, Yihua Liao, Reddy Adulla P., Zhong ZhaoPyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
    US-2006258728-A1November 16, 2006Kousuke Tani, Masaki Asada, Kaoru Kobayashi, Masami Narita, Mikio OgawaCarboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
    US-6437146-B1August 20, 2002Fujisawa Pharmaceutical Co., Ltd.Oxazole compounds as prostaglandin e2 agonists or antagonists
    US-6852863-B2February 08, 2005Pfizer Inc.Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid

NO-Patent Citations (0)

    Title

Cited By (2)

    Publication numberPublication dateAssigneeTitle
    CN-105198786-ADecember 30, 2015中国医学科学院医药生物技术研究所芳基取代的酰胺类化合物及其制备方法、包含其的药物组合物及其应用
    KR-101082414-B1November 10, 2011충북대학교 산학협력단신규한 나프탈렌 유도체 화합물 및 이를 유효성분으로 포함하는 면역 증강용 약제학적 조성물